CORONA Main Coronavirus thread

Heliobas Disciple

TB Fanatic
(fair use applies)


Study finds a reduced risk of serious cardiovascular disease after COVID vaccination

by University of Gothenburg
October 1, 2024

People who have been fully vaccinated against COVID-19 have a significantly lower risk of developing more severe cardiovascular conditions linked to COVID-19 infection, according to a nationwide study at the University of Gothenburg. At the same time, some cardiovascular effects are seen after individual doses of the vaccine.

The COVID-19 vaccine aims to reduce complications and overall mortality from the disease. A rare acute side effect is inflammation of the cardiac muscle or the pericardium in young men following mRNA vaccination. In terms of other cardiovascular effects, there has only been limited research and the results have been conflicting.

Published in the European Heart Journal, a register-based, nationwide study is based on data from the entire population of more than eight million adults in Sweden who were followed up in national health care registers for around two years, from the end of December 2020, when COVID-19 vaccination began, until the end of 2022.

The researchers have studied 'risk windows' (the time immediately after a single injection of the COVID vaccine), dose by dose, in those who were vaccinated. The cardiovascular health after full vaccination has then been compared with the cardiovascular health of those who, at the same stage of the study, had not started any vaccination.


Risk analyses for cardiovascular disease

The study includes risk analyses for a number of cardiovascular diseases related to both the heart and the brain: inflammation of the cardiac muscle or the pericardium, cardiac arrhythmia, heart failure, TIA, and stroke—the latter two being caused by impaired blood flow in the brain.

For most of the outcomes—particularly the more serious ones—there was a reduced risk of cardiovascular events after vaccination, especially after the third dose. The risk of cardiovascular events after being fully vaccinated was generally 20–30% lower than if no vaccination had been initiated.

At the same time, the study also confirms the increased risk of inflammation of the cardiac muscle or the pericardium one to two weeks after a single mRNA injection against COVID.

The study also observed a temporarily increased risk of extrasystoles—additional heartbeats—after dose one (17% higher risk) and dose two (22% higher risk), and this was stronger among elderly and males. There was no increased risk of other serious cardiac arrhythmias after being vaccinated.

The risk of stroke was lower after vaccination than without vaccination, while the risk of TIA was temporarily higher (13% higher risk) after a single dose of vaccination, mainly in older men.
Protective benefits of the vaccine

The research was carried out at the School of Public Health and Community Medicine at the University of Gothenburg's Sahlgrenska Academy, with Fredrik Nyberg, a Visiting Professor in Register Epidemiology, and Yiyi Xu, an Associate Professor in Occupational and Environmental Medicine, having main responsibility for the study.

Other authors include Mats Börjesson, a cardiologist and Professor of Sports Physiology, and Magnus Gisslén, an infection specialist, Professor of Infectious Diseases, and State Epidemiologist.

"The increases in cardiovascular risk we saw following COVID-19 vaccination are temporary, and do not apply to the more severe conditions," says Professor Nyberg.

"On the other hand, full vaccination significantly reduced the risk of several more severe cardiovascular outcomes linked to COVID-19, such as heart attack, stroke, and heart failure. This emphasizes the protective benefits of full vaccination."

More information: Yiyi Xu et al, Cardiovascular events following coronavirus disease 2019 vaccination in adults: a nationwide Swedish study, European Heart Journal (2024). DOI: 10.1093/eurheartj/ehae639
Journal information: European Heart Journal
Provided by University of Gothenburg
 

Heliobas Disciple

TB Fanatic
(fair use applies)


‘Striking Evidence’ COVID Shots May Increase Kids’ Risk of Asthma
A new analysis of over 200,000 U.S. children’s health records suggests that mRNA COVID-19 vaccination increases the risk of asthma, Alex Berenson reported. The Taiwanese researchers who conducted the analysis have not yet published their findings.

by Suzanne Burdick, Ph.D.
October 2, 2024

A new analysis of over 200,000 U.S. children’s health records suggests that mRNA COVID-19 vaccination increases children’s risk of asthma, Alex Berenson reported Tuesday.

Berenson, a former New York Times reporter who now reports on his Unreported Truths Substack, revealed communications with Taiwanese researchers showing they found “striking evidence” that the shots themselves may cause asthma, which leads to lung damage.

Asthma is a chronic lung disease affecting nearly 5 million U.S. children, according to the Centers for Disease Control and Prevention (CDC). While usually not fatal, severe asthma attacks can be life-threatening in children, according to the Mayo Clinic.

The Taiwanese researchers’ analysis — which the researchers are still reviewing — used electronic medical records from TriNetX, which touts itself as the “largest global source of real-world data.”

The study authors looked at TriNetX’s health data from over 200,000 U.S. kids ages 5 to 18 between Jan. 1, 2021, and Dec. 31, 2022.

According to Berenson, they found that children who received a COVID-19 mRNA shot and who had not had a natural COVID-19 infection had a 13% higher risk of receiving a new asthma diagnosis in the year after their vaccination when compared to a matched group of children who didn’t get a COVID-19 shot or infection.

“That increased risk cannot be due to Covid, since neither group was infected,” Berenson wrote.

When the researchers compared vaccinated versus unvaccinated children — all of whom also were diagnosed with a COVID-19 infection — they found an even higher risk.

Berenson reported that children who had both a COVID-19 mRNA shot and a COVID-19 infection had a 20% higher risk of a new asthma diagnosis than a similar group of unvaccinated kids who had a COVID-19 infection.

Because the study is not a randomized prospective trial it does not prove that the mRNA COVID-19 shots caused the extra asthma cases, Berenson said.

“But the researchers closely matched two very large groups,” he wrote, “and the association they found is almost certainly not due to chance.”


‘They may have some trouble getting a major or even minor journal to accept their results’

The researchers disclosed their results to Berenson in an email — which he posted on his Oct. 1 Substack post — in response to his questions about a study they published June 21 in the peer-reviewed journal Infection.

In the June study, the Taiwanese authors looked at TriNetX data records from 304,500 U.S. children and found a “strong link between COVID-19 infection and an increased risk of new-onset asthma in children.”

Though they hadn’t hypothesized that vaccination would be linked to an increase in asthma, the study authors found that the increased risk was “more marked in those vaccinated.”

Berenson wrote on Substack:

“But because the researchers had not matched the groups by vaccine status in the initial study, the vaccinated group was notably less healthy than the unvaccinated group at baseline. …So the jabbed and unjabbed cohorts could not be directly compared.”

Berenson asked the researchers in an email if they had run a parallel version of the study that directly compared outcomes by vaccination status and, if so, could they disclose the results.

“To my surprise, they responded,” Berenson told The Defender. They didn’t say when they would publish the results.

“If history is any guide,” Berenson said, “they may have some trouble getting a major or even minor journal to accept their results — journals have been very wary of publishing negative research on the mRNAs outside of myocarditis, which is an acceptable topic to discuss.”


Pediatrician: Asthma symptoms similar to anaphylaxis

Dr. Lawrence Palevsky, a pediatrician, told The Defender that many asthma symptoms are the same as those associated with anaphylaxis, a severe allergic reaction.

Coughing, wheezing, bronchospasm, shortness of breath, rapid breathing/dyspnea and hypoxia — these airway symptoms occur when the immune and nervous systems are significantly activated in response to exposure to one or more allergens the body perceives as a threat.

“If COVID injections seem to increase children’s risks of developing asthma, or anaphylaxis, this signifies there may be one or more ingredients in these injections that pose a threat to the health and safety of their immune and nervous systems,” Palevsky said. “It would make sense to avoid instigating anaphylaxis in children, no?”

Berenson criticized the CDC for continuing to recommend the COVID-19 shots for kids:

“I am stunned that the Centers for Disease Control will not admit defeat and drop its recommendation for them — though as a practical matter almost no one under 18 is getting them now.
“But in continuing to press them, the CDC is further damaging its credibility, if it has any left at this point.”


First study finds ‘strong link’ between COVID infection and asthma in kids — especially for the vaccinated

Berenson said the Taiwanese researchers’ finding about a possible link between COVID-19 vaccines and asthma was “particularly striking” because they weren’t looking for it.

They conducted the June 21 study using children’s health data from TriNetX to determine if there might be a link between COVID-19 infection and asthma.

In their report, they explained that they used a cohort-matching technique before doing their analysis to minimize the likelihood of getting biased results due to confounding factors.

Using the matching technique, they created an unvaccinated group that included equal numbers of kids — 128,753 — who had and hadn’t had a COVID-19 infection.

They compared the data from that group to a vaccinated group that also included equal numbers of kids — 23,497 — who had and hadn’t had a COVID-19 infection.

They found that the children infected with COVID-19 showed a significantly increased incidence of new-onset asthma during the year after the infection compared with kids who hadn’t had a COVID-19 infection — and the finding was consistent across gender, age and racial groups.

They also found that the increased risk of new-onset asthma was “more marked” in those children who had COVID-19 and also received an mRNA COVID-19 vaccine.

Berenson noted in his Oct. 2 Substack post that the Taiwanese authors’ June study has received little attention, despite the vaccine safety signals it contains.

In addition to finding that the link between COVID-19 infection and asthma was stronger in kids who got a COVID-19 shot, the study authors found that children who received a COVID-19 shot were 6 times more likely to die during the next year than kids who didn’t get a COVID-19 shot.

The most likely explanation for the difference is that the kids in the vaccinated cohort were sicker to begin with, compared to the unvaccinated. For instance, the kids in the vaccinated cohort had higher rates of diabetes and psychiatric disorders, according to Berenson who reviewed the study.

“Nonetheless,” Berenson wrote, “the gap is large enough that in any sane world researchers at the Centers for Disease Control and elsewhere would be following it up, if only to rule it out and figure out if other databases have any similar signals.”

The Taiwanese authors noted in their June study that other recent studies have also found a link between viral infections — including COVID-19 — and asthma.

However, there is still scientific debate about the degree to which that may occur in children.

A 2022 study published in BMC Infectious Diseases that analyzed roughly 70 kids hospitalized for COVID-19 reported that 41.5% had asthma-like symptoms when discharged. Less than 16% of those children had a history of asthma when admitted to the hospital. The study did not report vaccination status.

However, an April study published in Pediatrics involving almost 30,000 children concluded that testing positive for COVID-19 wasn’t associated with a new asthma diagnosis within 18 months of the infection.

The Defender reached out to the Taiwanese study’s corresponding author but did not receive a response by the deadline.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


Spike Protein From SARS-CoV-2 Worsens Stroke Risks
Nikhil Prasad Fact checked by:Thailand Medical News
Oct 03, 2024

A team of researchers from Mercer University and South University in Savannah, Georgia-USA, has uncovered alarming evidence that the spike protein of the SARS-CoV-2 virus, responsible for COVID-19, may significantly increase the risk of stroke and related neurological issues. This Medical News report delves into how the viral spike protein exacerbates clotting problems, leading to higher chances of stroke, brain inflammation, and cognitive decline. The study used an experimental model involving humanized ACE2 knock-in mice to demonstrate these findings.

The research brings to light how the spike protein can increase blood clotting while interfering with the body’s ability to break down clots. These findings add to growing concerns about the long-term impacts of COVID-19 on the brain and its role in causing or worsening stroke.


Understanding the Role of the Spike Protein
The spike protein of SARS-CoV-2, which allows the virus to enter human cells, has already been linked to various complications. The study focused on how this protein affects the balance of the renin-angiotensin-aldosterone system (RAAS), which helps regulate blood pressure and fluid balance in the body.

Normally, RAAS plays a crucial role in preventing excessive blood clotting and protecting blood vessels from inflammation. However, when the spike protein disrupts this system, it tips the balance toward clot formation, inflammation, and poor blood flow in the brain. As a result, individuals who have had COVID-19 may face an increased risk of stroke, even after their initial infection has passed.


The Research Process: A Closer Look at the Study
To better understand this connection, researchers injected the spike protein into humanized ACE2 knock-in mice, which are engineered to have human-like ACE2 receptors - just like humans, these receptors allow the spike protein to attach and cause damage. The team then induced a stroke in these mice to examine how the spike protein affected the brain’s ability to cope with blood clots and ischemic (lack of blood flow) injuries.

Their results were alarming. The spike protein caused an imbalance in RAAS, leading to an increase in clotting and a decrease in the body’s ability to break down clots. This imbalance resulted in reduced blood flow to the brain, greater brain cell death, and cognitive impairments.


Key Findings: Spike Protein Increases Stroke Risks
One of the major findings of the study was that the spike protein increased the expression of tissue factor III (TF-III) and plasminogen activator inhibitor-1 (PAI-1). Both of these proteins play a significant role in clot formation and breakdown. Under normal circumstances, the body carefully controls the balance between clotting and dissolving clots to prevent excessive bleeding or clotting. However, the spike protein disrupted this balance.

Tissue Factor III (TF-III): This protein triggers the body’s clotting system. The study showed that the spike protein caused a significant increase in TF-III, which led to a higher risk of clots forming in the brain’s blood vessels.

Plasminogen Activator Inhibitor-1 (PAI-1): This inhibitor blocks the body’s ability to break down clots, leading to the persistence of clots in the bloodstream. When combined with the increase in TF-III, the spike protein made it more difficult for the body to clear these dangerous clots, leading to a higher risk of stroke.

In addition, the spike protein also caused a significant reduction in cerebral blood flow, a key factor in stroke outcomes. The decreased blood flow increased the amount of brain damage in the mice, which directly translated into poorer cognitive outcomes.


Cognitive Decline and the Spike Protein
Another key aspect of the study was its focus on the effects of the spike protein on cognitive function. Even though the mice were able to recover from the initial stroke, those that had been exposed to the spike protein showed much more severe cognitive decline. This included problems with memory and learning, as measured by the novel object recognition test, which assesses how well mice remember new objects compared to familiar ones.

These cognitive deficits are particularly concerning given the increasing number of people who have recovered from COVID-19 but continue to experience neurological symptoms such as brain fog, difficulty concentrating, and memory loss. The study suggests that the spike protein may be responsible for these lingering issues by causing damage to the brain’s blood vessels and disrupting blood flow.


Treatment Options: Losartan Shows Promise

The study also explored potential treatment options for reducing the harmful effects of the spike protein on the brain. Researchers found that Losartan, a drug commonly used to treat high blood pressure, was able to restore the balance of RAAS and reduce the spike protein’s effects.

Losartan works by blocking the angiotensin II type 1 receptor (AT1R), which is one of the key drivers of the clotting and inflammatory effects caused by the spike protein. By restoring the balance between angiotensin II and the protective arm of RAAS, Losartan was able to improve blood flow in the brain and reduce the risk of stroke and cognitive decline in the mice.

While Losartan is already widely available and used to treat high blood pressure, its potential as a treatment for COVID-19-related complications is still being explored. The results of this study suggest that it may be a promising option for people at high risk of stroke or cognitive decline after recovering from COVID-19.


Conclusion: Spike Protein’s Long-Lasting Effects

The findings of this study underscore the importance of understanding the long-term effects of COVID-19, especially on the brain and nervous system. As researchers continue to uncover the ways in which the spike protein affects blood clotting and brain function, it becomes clear that the risks of stroke and cognitive decline may persist long after the initial infection has passed.

For those who have recovered from COVID-19, especially those who already have risk factors for stroke, it may be crucial to monitor their health closely and consider treatments like Losartan that can help mitigate these risks. The spike protein’s ability to disrupt the body’s natural clotting mechanisms and cause brain damage highlights the need for ongoing research and treatment strategies.

The study’s findings were published in the peer-reviewed journal: Translational Stroke Research.

 

Heliobas Disciple

TB Fanatic
(fair use applies)


The TRUTH About Covid Vaccine Immunity (IMPORTANT!)
Is the immune system treating the spike protein like a toxin?

Dr Philip McMillan
Sep 30, 2024

In this important session, I delved into a topic that many may find controversial but is grounded in scientific fact. I’ve spent years researching this, and the paper I’m discussing today, published on September 27, 2024, in Nature Medicine, provides insights that challenge the current pandemic narrative. The implications of this research are significant, particularly in understanding the waning immunity from mRNA COVID vaccines.

This isn't about being anti-vax; it's about asking the right questions. Over the course of the pandemic, it’s become evident that after each booster shot, antibody levels drop quickly—sometimes within weeks—and by six months, a new booster is needed. This paper, examining long-term immunity, helps explain why: the mRNA vaccine does not lead to the establishment of long-lived plasma cells in the bone marrow, as other vaccines like those for tetanus and flu do. The immune system isn't keeping a memory of the spike protein.

To make sense of this, I compared this phenomenon to how the body reacts to gram-negative bacteria and their endotoxins. The immune system faces the infection but doesn’t retain a memory of it because remembering these toxins could lead to chronic diseases, inflammation, and even autoimmunity. Similarly, the immune system appears to be treating the spike protein from the mRNA vaccine as a toxin, refusing to retain it in long-term memory due to the potential for harmful autoimmune responses.

The paper's findings suggest that no matter how many doses of the vaccine are administered, long-lived immunity is unlikely to occur. This raises a critical question: why are we continuing to push boosters if the immune system is actively avoiding the spike protein? Public health strategies need to revisit the basics and reconsider their approach, especially since there is no long-term immunity being developed.

This revelation leaves us in a precarious situation where the current strategy is failing. With no long-term immunity and no alternatives, it’s time for the scientific community to ask some tough questions. What do we do next?

I’ll continue to ask these challenging questions and keep you updated as we navigate these complex times. Thank you for joining me, and I hope this session encourages deep reflection on the current trajectory of public health policy.


Beginning of the video on youtube:
14 min 44 sec

View: https://www.youtube.com/watch?v=MFsxI-sIBXQ



FULL VIDEO AT ARTICLE LINK is 25 min 58 sec
 

Heliobas Disciple

TB Fanatic
(fair use applies)


The antibodies don’t protect you after all
Radagast

October 2, 2024

So we’re going to have to cover SARS2 once more. I know most people have moved on by now, but the global slow-motion lobotomy continues:

1act2024.jpg


These are test scores in young people. The obvious answer would be to blame the school closures. But that explanation would require test scores to bounce back by now, instead of continuing to decline. It’s similar to the surges in whooping cough and RSV. If the lockdowns are the reason, we should have caught up by now. Immune system damage better fits the pattern observed.

But the reason I want to go over the topic again, is to point out a problem I have addressed before: The antibodies don’t solve the problem. The literature used to be full of gloating infographics like this:

1hybridimmunity-1.jpeg



Neutralizing antibody concentrations are higher after vaccination! But if you now look at vaccinated healthcare workers, you see the problem I already warned about long ago: The quality of the immune response is poor. The IgG antibodies shifted to IgG4 and IgG2 (which can’t form cross-links and tell Natural Killer cells to ignore infected cells), have relatively poor affinity and bind to the wrong regions, including to regions where they enhance the ability of viral particles to infect cells.

This is confirmed by a new study in healthcare workers, where they found that higher concentrations of IgG antibodies to Spike, lead to repeated reinfections. On the other hand, higher levels of interferon gamma and interleukin 2, were found to lead to protection from reinfection. So this is why we’re stuck, with these endless waves of infections, including during the height of summer.

I have explained before, that vaccination results in a deficient interferon gamma response. I showed you this graph:

nointerferon.png



It’s interferon gamma, secreted by T cells and NK cells, that allows infected cells to clear an infection themselves, by synergizing with the interferon alpha produced by infected tissues. In its absence, the immune system is forced to kill infected cells instead. But if people were vaccinated before their first infection, which most people were, the body ends up stuck with low concentrations of interferon gamma.

People who were infected before being vaccinated, have an immune response that’s able to recognize various genes other than Spike and manages to produce interferon gamma in response to those genes. But when people were vaccinated before infection, the immune system is stuck with very high concentrations of antibodies to Spike and an inability to produce enough interferon gamma.

It’s worth sharing this graphic again, which offers some basic insight into what interferon gamma does:

1interferongamma-1024x713.jpg


As you can see, Interferon Gamma interferes in just about every step in the viral reproduction cycle. It’s the sort of mechanism the body evolved that works well for numerous viruses, instead of being specific for any particular type. Low interferon gamma levels have been found to lead to a massively increased risk of hospitalization. It allows you to predict who will be hospitalized upon infection: If you don’t see interferon gamma jump up, they’ll probably end up hospitalized.

As long as all of this continues, people just get sicker and sicker.

But I would have expected, that the people who perform these studies would open their mouths by now. I would expect that you don’t have to visit some obscure Dutch blog to hear about these problems.

If you do a study, where you find that:

-Antibodies have shifted to IgG4/IgG2

-Higher concentrations of antibodies lead to increased risk of constant reinfections

-Interferon gamma becomes absent when vaccinating naive people.

I would expect that you feel a responsibility, to warn that we can’t go on vaccinating people. More importantly, I would expect you to feel a responsibility, to warn that a big mistake has been made.

And there are a handful of people who actually do ring the alarm bells. In one study, they concluded:
Knowing that the mRNA vaccines do not prevent infections, the Omicron subvariants have been shown to be less pathogenic, and IgG4 levels have been associated with immunotolerance and numerous negative effects, the recommendations for the successive administration of booster vaccinations to people should be revised.
So it’s not just me, making stuff up or misinterpreting things.

But in general, the pattern seems to be that the vast majority of people just want to forget what happened.

But you can’t afford to ignore what’s going on. Your first infection reduces your IQ by 3 points, the second by 2. After the first infection, your immune system basically knows how to deal with this, so the third infection probably has an effect similar to the second.

And if you think these are just weak correlational studies, well, they actually went ahead and had healthy young people voluntarily infected by this virus and they found out those people were left with brain-damage that doesn’t go away.

How this managed to get through an ethics committee, I have no idea, but they went ahead and did this.

When I look around and talk to my friends, I notice their personalities are just changing. They’re becoming less social, more introverted, more anxious, more stuck with repetitive interests, less able to enjoy new things.

What do you think this is:
During the first phase of the pandemic (March to December 2020), personality was relatively stable, with only a small decline in neuroticism compared with pre-pandemic. This could be down to Covid “providing a reason” for feelings of anxiety and making it less likely for people to blame their own disposition, the authors suggested.
The reduction in neuroticism had disappeared by the second half of the pandemic (2021-2022), the study suggested, and was replaced by declines in extraversion, openness, agreeableness, and conscientiousness compared to pre-pandemic personality. The changes were about one-tenth of a standard deviation, equivalent to the size of fluctuation typically seen over a decade of life. Younger adults showed the biggest changes and the oldest group of adults had no significant changes in traits.
This is personality change, from brain damage and an immune system forced to constantly be on high alert. All the inflammation depletes your brain of serotonin. You can’t blame the lockdowns for this, as it only emerged from 2021 onwards.

This is the main area where people’s brains are being damaged:

1MRI.jpg



This is the easiest part of the brain to get to for this virus, from the nerves in the nose. When this part of the brain is damaged, we’re not properly able to change our behavior when we no longer receive the same reward for what we’re doing anymore.

There is no more extinction of the association in our minds of a particular action with reward: If you once made a thousand bucks on a slot machine, but this part of the brain is damaged, then you’re going to keep pulling that lever. The same is true for unfulfilling jobs, unfulfilling relationships andsoforth. People get “stuck”, they’re no longer able to change to new patterns of behavior.

This is just really happening. It’s happening because everyone is constantly getting reinfected by this virus. Everyone is constantly getting reinfected by this virus, because of the poor quality immune response you’re left with after vaccination.

But if your body fails to deploy a proper inflammatory immune response to this virus, then you won’t even notice this is going on. Your small blood vessels in your brain become covered in amyloid, without you noticing anything is wrong. It becomes a stealth lobotomy.

1negativeefficacy1-3-1024x570.jpg


The end result, is that basically everyone ends up with long COVID. Risk of long COVID goes up linearly with every reinfection, it does not decline during reinfections.

There are things you can do of course. Taurine and vitamin C seem to help the immune system recover. Natto and serrapeptase break down the fibrin clots that form, psilocybe mushrooms help repair the blood vessels.

But most people don’t seem to want to see any of this. They ignore the fact that they can’t smell anything, ignore that they’re constantly coughing, ignore that they’re rapidly out of breath.

And they’re self-medicating, without realizing it.

Why do you think the United States now has an Adderall shortage? Prescriptions of Adderall in the US doubled between 2020 and 2022. It’s an amphetamine drug, that causes your brain to release more dopamine and serotonin, but you rapidly develop a tolerance to it.

What is long COVID? It makes you feel depressed, tired, unable to concentrate and anxious. All problems that are reduced, when you use ADHD medication, to flood the brain with serotonin and dopamine. The American population is simply self-medicating their long COVID epidemic.

But it’s not a solution. The reduction in serotonin is a normal part of the brain’s innate immune response to a viral infection. If you start treating that with amphetamines, you’re just masking the underlying problem.
 

Heliobas Disciple

TB Fanatic
SOME COMMENTS FROM ABOVE ARTICLE; RADAGAST IS THE WRITER AND HE'S RESPONDING TO THESE 2 COMMENTS



meh
October 2, 2024 at 2:46 pm

i haven’t finished your article but the premise is flawed: it’s in no way true that test scores should have recovered by now at all. the kids taking these tests last year had their high school experience basically cut in half so of course they couldn’t have caught up in 2 years. also, just because kids are physically in school doesn’t mean it’s like it was before COVID. a lot of the stupid political policies that were implemented to game the metrics but actually hurt learning are permanent now, so schooling in general has somehow, improbably, gotten worse. now i’ll read the rest of your article after running my mouth off.


Radagast
October 2, 2024 at 3:20 pm

If it’s school closures, you would expect Sweden’s ranking to improve compared to the rest of the world.

What we see is that Sweden’s ranking declined:


>School closures during the Covid-19 pandemic were one factor behind the unprecedented decrease across the OECD, with Pisa finding that “students in systems that spared more students from longer closures scored higher in mathematics and reported a greater sense of belonging at school”.

>Fifteen percent of students in Sweden reported that their school building was closed for more than three months during the pandemic, compared to 51 percent of OECD students on average.

>But school closures don’t appear to have been a decisive factor, with Sweden’s results falling more sharply than the OECD average (maths -15, reading -10, and no significant change in science).

It’s brain damage.






LSWM Lives Matter
October 2, 2024 at 2:55 pm

Thanks for another update.

> But if your body fails to deploy a proper inflammatory immune response to this virus, then you won’t even notice this is going on. Your small blood vessels in your brain become covered in amyloid, without you noticing anything is wrong. It becomes a stealth lobotomy.

This is something that I’ve been thinking about lately. The vaccine-induced IgG4 antibodies against the RBD are anti-inflammatory, meaning that they reduce symptoms of an infection in the vaccinated.

But, you’ve also written before that IgG antibodies can’t cross the blood brain barrier. I was asking ChatGPT about this, and “it” told me that under certain circumstances, IgG antibodies can indeed cross the BBB.

So, presumably this must be happening to some extent. Because otherwise, the vaccinated would be complaining about constant headaches.

And you’ve also written how the CD8+ killer T cells are also playing a role in the vaccinated immune response, but this is bad because it kills the brain cells. But if the IgG4 antibodies are crossing the BBB, and they shut down ADCC, then presumably these killer T cells are no longer doing their job? Which would be “good” (in the sense that these T cells are no longer “trigger happy”) but “bad” (in the sense that it could be causing persistent infections in the brain).

So, perhaps up until now, the unvaccinated have suffered more brain damage than the vaccinated, but this trend will reverse in the future once more fusogenic variants start disseminating. Very complex and difficult to predict what exactly is going to happen over the next several years, and terrifying to think about.

However, because XEC seems to be outcompeting KP, it seems that there is still room for the virus to further increase its ACE2 affinity, which is good, because it will outcompete more glycosylated variants, meaning that it should further delay the arrival of HIVICRON. I was really worried that it would happen this Winter. Not that this Winter won’t be bad, but hopefully the hospitals will be able to cope.


Radagast
October 2, 2024 at 3:29 pm

>And you’ve also written how the CD8+ killer T cells are also playing a role in the vaccinated immune response, but this is bad because it kills the brain cells. But if the IgG4 antibodies are crossing the BBB, and they shut down ADCC, then presumably these killer T cells are no longer doing their job?

ADCC is NK cells, not the CD8 T cells.

A CD8 Killer T cell just look at whether the MHC molecule of the cell is expressing its antigen. This is easy to avoid, by a virus just reducing expression of the MHC molecule altogether.

This is why it’s questionable whether the CD8+ T cells really do anything useful at all when it comes to this virus, some argue they just make matters worse.

>However, because XEC seems to be outcompeting KP, it seems that there is still room for the virus to further increase its ACE2 affinity,

No, XEC seems to beat KP through internal genetic differences, rather than due to Spike changes.

See Ryan Hissner’s recent posts on this, on Twitter.

>I was really worried that it would happen this Winter. Not that this Winter won’t be bad, but hopefully the hospitals will be able to cope.

Honestly, we don’t really know and can’t really know.

All we know is that these antibodies that target the NTD are unsustainable and easily avoided through multiple routes.

-Glycans
-Cysteine pair changes, to change how the protein is folded
-Increased fusogenicity
-Decreased immunogenicity (mutate to resemble our own proteins more)

We’re seeing all of these to some degree. We mostly see glycans, but also a new cysteine popping up suddenly.

And there’s apparently also a way to avoid NTD antibodies by binding heme metabolites:

https://www.science.org/doi/10.1126/sciadv.abg7607

Because the NTD doesn’t have to be able to bind to the ACE2 receptor, there are far more routes available for it to avoid the antibodies.

So how long it’s going to take it, to make the antibodies useless and what that’s going to look like, is really hard to guess, but for now it mostly seems to be happening mostly through more and more glycans being added.

If you look at the mutations popping up in the NTD, it’s almost all like this:

[letter]->N
[letter]->S
[letter]->T

All of that suggests new glycans being added.
 

naegling62

Veteran Member
Just an anecdotal observation to back up post #71,605. I’ve stated this many times, my daughter works in a Military/NASA child care facility. All the workers are vaccinated, most of the parents and children are also. They are constantly sick from everything plus they keep catching Covid over and over. It’s nuts how sick these people are! It doesn’t matter what season it is!

My daughter is not vaccinated.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


Remember the shortage of medical gowns during COVID? Feds spending $350 million for stockpile
Amanda Seitz
Thu, October 3, 2024, 4:32 PM EDT

WASHINGTON (AP) — Six U.S. companies will spend at least $350 million to manufacture medical gowns to store in the Strategic National Stockpile, years after doctors and nurses working in hospitals found themselves without the equipment while COVID-19 raged.

The purchase of the gowns is one of the final steps toward shoring up the personal protective equipment in the stockpile after it was depleted just weeks into the COVID pandemic. Equipment had not been regularly restocked in the years before the crisis began.

The new gowns are among the many purchases the Administration for Strategic Preparedness and Response has made in recent years to restock the emergency coffers, assistant secretary Dawn O'Connell said.

The administration wants to “make sure the country would never be caught in the same position they were in 2020, when the stockpile was opened on one of our worst days, one of our worst months, and people couldn't find what they needed in it," O'Connell said.

A range of U.S. companies were selected to manufacture the gowns, including a California lacrosse equipment maker and a New York embroidery studio.

In total, about 250 million gowns should be manufactured under the deal. It'll leave the stockpile with about a 90-day supply of the gowns should another emergency hit. The agency has also stockpiled 1.5 billion gloves and 1.1 billion masks.

The Strategic National Stockpile is supposed to keep a robust supply of medicines, vaccines, medical equipment and supplies at the ready for disasters and pandemics.

But that didn't happen in 2020, when COVID-19 started its spread in an outbreak that would ultimately kill more than 1.2 million people in the United States and millions more around the globe.

The early days of the pandemic were marked by images of doctors and nurses wrapping themselves in trash bags. People turned to cloth masks after medical masks became virtually impossible to find. Companies illegally gouged the price of some medical necessities, like gloves or masks. And many states were left to purchase the products on their own, without help from the federal government.

Some states even bought too much, leaving them with a glut of hastily purchased medical equipment, some of them cheaply made or expired. States, an Associated Press investigation found, have trashed millions of gloves, masks and gowns in recent months.

“States had to act on their own," O'Connell said. "There were a lot of panic purchases that were done."
 

Heliobas Disciple

TB Fanatic
(fair use applies)


Here's why B cells benefit from booster shots
by Rockefeller University
October 3, 2024

Certain infectious diseases, such as COVID or the flu, evolve constantly, shapeshifting just enough to outmaneuver our immune systems and reinfect us repeatedly. But subsequent reinfections often don't lead to the most severe outcomes—for very good reason.

Upon first exposure to a pathogen, our immune systems churn out specially trained B cells, which have learned to identify and eliminate the virus. Later, those B cells remain primed and ready to produce powerful recall antibodies.

Scientists long thought that the body ultimately cleared these types of infections essentially by getting old immune cells up to speed: refining those previously trained in germinal centers, which are the specialized structures in our lymph nodes and spleen where B cells learn to identify and eliminate threats.

But recent work suggests that "recall germinal centers"—those formed upon re-exposure—are actually generating a different, second line of defense. By drawing heavily on naive and untrained B cells, these reactivated centers focus on developing entirely new antibodies, while the experienced B cells spring directly into action.

A new study in Immunity explains how this two-tiered system benefits the immune response, with results that have implications for vaccine-boosting strategies.

"We investigated the underlying principles that explain how the body responds to repeat exposures, whether to a vaccine or virus, and how recall germinal centers shape that response," says first author Ariën Schiepers, a graduate student in the laboratory of Gabriel Victora.

For the study, Victora, Schiepers, and colleagues examined mice repeatedly immunized with the same antigen and assessed the antigen-binding abilities of recall B cells. What they discovered was that existing antibodies, derived from B cells that had weathered the first infection, were actively preventing B cells with overlapping specificities from entering recall germinal centers. When they boosted mouse models with variants of the original virus, they found out why this system makes sense.

In response to a viral variant, the recall germinal centers were guiding naive B cells toward the new antigenic target. This prevents the immune system from investing in B cells from a prior infection—and repeatedly churning out antibodies that target a bygone virus.

"It's an elegant feedback system, with antibodies generated in the first response aiding in shaping new antibodies toward the variant," Schiepers says. "Recall germinal centers are like librarians adding new titles to the immune system's library, ensuring it does not just retrieve the same old book again and again."

The findings suggest implications for booster shots. While traditional boosters work well for childhood vaccines by increasing antibody levels, the approach becomes more complex with evolving viruses. Boosting with a variant antigen may reduce overlap with previous antibodies and allow the immune system to better target new variants.

"This demonstrates exactly why there's a real advantage in boosting against a variant," Schiepers says.

More information: Ariën Schiepers et al, Opposing effects of pre-existing antibody and memory T cell help on the dynamics of recall germinal centers, Immunity (2024). DOI: 10.1016/j.immuni.2024.05.009
Journal information: Immunity
Provided by Rockefeller University
 

Heliobas Disciple

TB Fanatic
(fair use applies)


Nondisclosure: Vaccine Ad Blitz Sidestepped Transparency Rules
The FDA's emergency approval of the mRNA vaccines required enhanced disclosure in all vaccine advertising and marketing. Pfizer and Moderna dodged the rules.

Lee Fang
Oct 03, 2024

This investigation was reported in collaboration with RealClearInvestigations.

“A bun in the toaster oven,” a woman exclaims off-camera, handing an ultrasound image to family members who erupt into tearful emotion over the news. “Oh my God!”

The touching baby announcement video then gets down to business as text appears on the screen amidst the ongoing celebration, suggesting the best way to stay alive for this joyous birth is by becoming vaccinated against COVID-19. “Why will you get vaccinated? … Because some people you just want to meet in person.”

It closes with the tagline: “Science can make this possible. Only you can make it real.”

The evocative 2021 television spot was funded by Pfizer just as the pharmaceutical giant was rolling out its COVID-19 vaccine. The spot may have seemed like any other pharmaceutical advertisement. But there was something missing. The ad, and many others like it financed by vaccine manufacturers, did not include any of the typical disclaimers about risks associated with vaccines, nor any disclosures that they had not yet received Food and Drug Administration approval.

Although Pfizer and other pharmaceutical companies were operating under a special Emergency Use Authorization (EUA) that allowed them to sell their COVID vaccines without going through the traditional testing and approval process, that authorization explicitly required vaccine ads to include a prominent warning that the medicines had not been fully tested for potential risks.

A RealClearInvestigations review of ads that ran tens of thousands of times during the pandemic found that the major vaccine companies routinely exploited a regulatory loophole to skirt those marketing rules while embarking on massive paid media campaigns to sell the COVID-19 vaccines. By casting their spots as public service announcements – promoting the idea that people should get vaccinated, rather than a company’s specific product – drug companies claimed the disclosure requirements did not apply.

As a result, the required disclosure about the vaccine operating under emergency approval rarely appeared in any of the ads, even as many employers, including the federal government, required tens of millions of Americans to get vaccinated.

“It’s an advertising laundering operation,” said Aaron Kheriaty, a bioethicist and fellow at the Ethics and Public Policy Center. The ads “violate the spirit of the EUA, if not the letter of the law.”

The ad blitz was plastered across television and social media and later celebrated by drug industry insiders as one of the most effective pharmaceutical outreach campaigns of all time. The flood of ads not only promoted Pfizer and Moderna’s products but helped influence public opinion, transforming an industry once viewed as driven by greed into altruistic heroes stepping up to solve a health crisis with no ulterior motives.

WPP, the advertising conglomerate that crafted Pfizer’s “Science Will Win” ad campaign during the pandemic, was clear about the motivation when speaking to a trade outlet. “‘Science Will Win’ campaign was about changing the perception that pharmaceutical companies profited from health and from sickness,” Claire Gillis, the international chief executive officer of WPP Health Practice, boasted to The Drum, a marketing industry outlet.

Yet the role of the COVID-19 vaccine ads, which widely shaped public opinion and galvanized support for the drug industry, remains largely unexplored. Critics say it is another example of rules for pharmaceutical companies that were tossed to the wayside as maximalist policies swept through society. Online censorship, vaccination mandates, school closings, general lockdowns, and other draconian restrictions were imposed on citizens, while drug companies poised to reap unprecedented multi-billion dollar profits were given unusual and largely unscrutinized leeway.

The attorneys general of Texas and Kansas have accused Pfizer of widely misleading the public on the effectiveness of its vaccine. Both states contend that the company violated rules that bar pharmaceutical firms from deceptive messaging, though their lawsuits largely focus on statements by company officials. Pfizer has denied that it misrepresented the vaccine and said in court documents that it is “immune” from claims since the company was acting under authorization from the federal government.

These so-called “direct-to-consumer” drug ads are a contentious area of public health. The United States and New Zealand are the only countries that permit such ads. A study from the Government Accountability Office found that from 2016 through 2018, drug manufacturers spent $17.8 billion on direct-to-consumer ads for just 553 drugs, almost all of which were brand name. Experts have sharply criticized the ads for misleading patients and encouraging many to seek out medications that are not clinically appropriate.

The tsunami of drug ads began in 1997 when Congress lifted previous restrictions and allowed pharmaceutical ads as long as they contained a summary of the risks of each product at the end of the commercial. This has given many ads a whiplash quality, as sunny visions of a medicine’s benefits are followed by a parade of horribles regarding common side effects ranging from hallucinations and nausea to strokes, suicidal ideation, and even heart attacks.

However, COVID ads from Pfizer that ran nationally during the early rollout of the vaccine contained no basic disclosure, despite the fact they were marketing a drug that had enhanced disclosure requirements. The risks around myocarditis and other heart issues were not acknowledged in spots, nor were the relative lack of benefits for young, healthy individuals with prior infection immunity.

The most glaring omission, however, was the lack of disclosure that the vaccines had not yet received FDA approval. Under the emergency approval to Pfizer and Moderna, issued in December 2020, both pharmaceutical firms were required to remind viewers of the EUA status of the vaccines in any paid media. It stated that “all descriptive printed matter, advertising, and promotional material” relating to the vaccine must “clearly and conspicuously” state that “this product has not been approved or licensed by FDA” and was authorized only under the emergency use declaration.

Those disclosures were almost nowhere to be found in countless advertisements that appeared over the ensuing months of the pandemic, as Americans faced widespread coercion to receive the shot.

In a response to a request for comment, a Pfizer spokesperson claimed that the ads were “unbranded campaigns,” and thus, no disclosures were required. Moderna provided a similar explanation. “As this was a non-branded disease education campaign EUA disclosures were neither necessary nor appropriate,” said a company spokesperson.

In other words, although both vaccine firms poured vast resources into marketing and advertising the vaccine, they did not mention the official brand names – Pfizer’s COMIRNATY and Moderna’s SpikeVax – and therefore, under this interpretation of the rules, neither the routine direct-to-consumer disclosures nor the EUA disclosures applied.

That justification strikes some medical ethics experts as pure sophistry.

“Since the COVID vaccines were approved under EUA, even unbranded ads should have carried the required warning,” noted Dr. Martin Kulldorff, a biostatistician and infectious disease epidemiologist, and critic of many vaccine policies.

The intent of the ads was clear to the marketing firms that managed them. WPP’s Gillis, in her remarks to The Drum, said that elevating the brand as part of the vaccine ads was very much the point. “Go to the doctor and ask for ‘Pfizer vaccine,’” she said, discussing the strategy.

Dini von Mueffling, a New York communications specialist who assisted with many of the Pfizer ads, later discussed the effort with Contagious, another marketing industry publication. The “many legal regulations,” said von Mueffling, “I think ultimately stymie creativity.” But, she added, “we worked within those regulations and were still able to be very creative, which was great.”

Pfizer ran many iterations of its “unbranded” COVID-19 vaccine campaign. The “Because of This” ad campaign featured real people rather than actors answering the question of why they will get vaccinated. “Because this year she turns one, and I’m 74,” the tagline of one Pfizer-sponsored ad read. Another, titled “Hug,” showed two women clutching each other, weeping. “Because you can’t hug a computer screen. Why will you get vaccinated?” the text of the ad asked, in a nod to the lockdown orders.

Moderna, while operating under the EUA, launched a “Make it Yours” campaign to encourage the use of its vaccine. The company brought on partnerships with the Seattle Seahawks and Boston Red Sox. One of the animated ads featured former Seahawks star Jordan Babineaux, who instructed viewers to “always protect the team” and get vaccinated. “With the vaccines here to help millions, we can take steps towards life as we knew it,” narrated Babineaux.

In other cases, third-party groups funded by Pfizer and Moderna blanketed viewers with ads urging vaccination without any disclaimers.

Immunize Nevada, a nonprofit that popped up during the pandemic and then disappeared, ran Facebook ads with a doctor imploring viewers to “get vaccinated.” GovVax, another group funded by vaccine industry sources, sponsored social media ads touting vaccines as “free, safe and effective.” The National Hispanic Medical Association, backed by grants from the vaccine pharmaceutical industry, similarly sponsored a “Get Vaccinated” social media campaign.

Pfizer also tapped the largely unregulated world of influencer marketing. In one instance, the company retained the public relations firm Real Chemistry and an influencer named Darrion Nguyen, who also goes by @Lab_Shenanigans, to create a series of comedic skits mocking vaccine misinformation. The series, titled “I Heard It on the Internet,” mocked critics of vaccine policy as fools who did not follow the science.

Nguyen, who identified himself as a “real life scientist,” produced videos debunking claims such as “vaccines don’t work with Omicron variants” and “vaccines can make you magnetic.” The latter was certainly not true, but the former was up for debate. Research from Israel showed that the Pfizer boosters provided as little as 30% efficacy against the Omicron wave – and other studies suggested at the time that natural immunity provided as much as 87.8% efficacy against the Omicron variant. Those facts were not included in the Pfizer-funded TikTok series.

The star of the Pfizer social media ads, however, later got into his own misinformation scandal. Earlier this year, Baylor College of Medicine in Texas retracted research authored in part by Nguyen, citing falsified data and fabricated lab results. Nguyen, in response to the news, cited “pressure to meet expectations.”

While few news outlets covered Moderna or Pfizer’s ad campaign at the time, both companies were widely celebrated by marketing professionals for the success of the blitz.

YouGov called Pfizer’s ads the most successful of 2020, while Medical Marketing and Media, an industry group, awarded Moderna, Pfizer, and Johnson & Johnson for their innovative marketing efforts.

Pfizer went so far as to submit a detailed presentation touting the impact of its social media and marketing strategy during the pandemic to the “Shorty Awards,” another industry competition for DTC ads and drug marketing innovation. The video montage of the company’s success shows a series of public relations victories for the industry, including a social media pledge to ensure a safe and effective vaccine, which won Pfizer “positive coverage from almost every top tier [news] outlet,” including the New York Times and Bloomberg.

The success in selling the public was buoyed by government support. The United States provided at least $31.9 billion in funds for the development, purchasing, and production of the mRNA vaccines, money that padded record profits. Pfizer generated some $37 billion in revenue from the vaccine in 2021, making it one of the most lucrative drug product launches of all time. Moderna, meanwhile, minted four new billionaires as the company’s stock skyrocketed.

Kheriaty, the bioethicist, is an opponent of all direct-to-consumer ads. But he noted that the vaccine industry campaign appeared particularly pernicious, as government and media voices largely echoed every marketing claim of the vaccine industry with little pushback, while the tens of millions of dollars of pharmaceutical ads provided an inherent conflict of interest for the news programs covering the pandemic.

“You’re probably just at the tip of the iceberg in terms of tracing the money flow,” Kheriaty sighed.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


A generation of babies growing up with brain damage
Radagast

October 3, 2024

So, most of you will be aware by now, of how governments have changed the methods of calculating excess mortality, so that it no longer looks like too many people are dying. The UK’s Office for National Statistics announced they reduced excess mortality by 20,448 in 2023, through this method:

In 2023, the new method estimates 10,994 excess deaths in the UK, which is 20,448 fewer than the current method.
— Office for National Statistics (ONS) (@ONS) February 20, 2024

In the Netherlands they’re doing something similar, they’re now including the pandemic years in their definition of baseline mortality, so the excess mortality no longer shows up in the numbers. It’s explained in Dutch here.

In countries like Ireland, Canada and New Zealand, you don’t have to change the definition of excess mortality, because the healthy immigrant effect solved the problem for you. An immigrant is about 50% less likely to die in the first few years after immigrating, than a native-born person of the same age. After all, you generally don’t migrate if you have down syndrome, schizophrenia, multiple sclerosis or some other condition that raises your risk of dying. The Irish population grew by 3.5% in 2023, due to immigration.

The record levels of immigration have the effect of reducing measured excess mortality rates in Western nations, particularly those in young adults.

But there are other problems that are harder to disguise. Consider the increase observed in babies with development delays and speech problems. Here you see the percentage of children in the United States diagnosed with speech delay at age two:

1speechdelay.jpg


You went from hovering around 9%, to an increase that started in late 2020 and has merely continued to go up since then. Pandemic restriction are gone, so that’s not it. It’s not tablets either, the increase only begins in 2020, the babies are stable until then. And these are newborn children, who were not vaccinated.

So what is it then? Well, we already know. In mothers infected by COVID during pregnancy, 20.3% have a child with a developmental delay at 12 months, compared to just 5.9% among mothers not infected. And of course the newborn babies who get infected will also suffer in their development.

So what’s the solution to this? Well easy of course, the same way we solve the excess mortality problem!

In 2022, the CDC published an update on developmental milestones for babies. Language skills that babies were supposed to have developed by 24 months, were pushed back, to 30 months instead.

So this is what you’re now faced with, if you have children in our day and age: A child who grows up with brain damage.

And of course, you can decide to wear a well-fitting mask during your entire pregnancy. But then when you give birth to the baby, what is the baby supposed to do? A baby can’t wear a mask. Are you going to send your children to kindergarten or the playground to play with the other kids, while they wear a respirator?

If you isolate a baby from grandma, from neighboring kids, from nature, you also end up with a developmentally stunted baby. If you teach your kid he has to wear a mask everywhere because there’s a virus out there damaging everyone’s brains, how do you think that impacts their psychological development? There is NO SOLUTION to this.

Here’s what the New York Times reported on July the 1st of this year:

Brook Allen, in Martin, Tenn., has taught kindergarten for 11 years. This year, for the first time, she said, several students could barely speak, several were not toilet trained, and several did not have the fine motor skills to hold a pencil.

This is what we’re now stuck with, a generation of children growing up with brain damage. Their immune systems are constantly fighting this virus, including in their brains, where the blood vessels are being damaged.

This is all a consequence of vaccinating everyone. When you vaccinate everyone, you ensure that you end up with wave after wave of this virus. It’s not going to get any better, until we see highly glycosylated variants emerge that break through the antibody response and leaves us with a population with a sufficiently strong trained innate immune response to prevent further waves.

The longer it takes before that happens, the worse the outcome ultimately gets, as we’re now seeing a whole generation of children growing up with brain damage.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


New Research: Lesser-Known Supplement Shows Promise in Relieving Long COVID Symptoms
By University at Buffalo
October 4, 2024

A UB researcher describes the findings as “a negative study with a positive twist.”

A small clinical trial conducted by the University at Buffalo found that low doses of lithium aspartate were ineffective in treating fatigue and brain fog, common symptoms of long COVID. However, a follow-up dose-finding study provided some evidence suggesting that higher doses may be effective.

Published in JAMA Network Open on Oct. 2, the study was led by Thomas J. Guttuso, Jr., MD, professor of neurology in the Jacobs School of Medicine and Biomedical Sciences at UB and a physician with UBMD Neurology.

“It’s a negative study with a positive twist,” Guttuso concludes.

Because long COVID is believed to stem from chronic inflammation and lithium has known anti-inflammatory actions, Guttuso had recommended that a patient of his try low-dose lithium for persistent long COVID symptoms. He was surprised when this patient reported a near-full resolution of fatigue and brain fog within a few days of initiating lithium aspartate at 5 milligrams a day.


Relief from symptoms

Based on this single case, Guttuso became interested in lithium aspartate as a potential treatment for long COVID and recommended it to other such patients.

According to Guttuso, 9 of 10 long COVID patients he treated with lithium aspartate 5-15mg a day saw very good benefit in terms of improvements to their fatigue and brain fog symptoms.

“Based on those nine patients, I had high hopes that we would see an effect from this randomized controlled trial,” says Guttuso. “But that’s the nature of research. Sometimes you are unpleasantly surprised.”

The randomized controlled trial showed no benefit from 10-15 milligrams a day of lithium aspartate compared to patients receiving a placebo.

After one patient from the study subsequently increased the lithium aspartate dosage to 40 milligrams a day and experienced a marked reduction in fatigue and brain fog symptoms, Guttuso decided to then conduct a dose-finding study designed to explore if a higher dose of lithium aspartate may be effective.

The three participants who completed the dose-finding study reported greater declines in fatigue and brain fog with the higher dose of 40-45 milligrams per day. This was especially true in the two patients with blood lithium concentrations of 0.18 and 0.49 millimoles per liter (mmol/L) compared to one patient with a level of 0.10mmol/L who saw partial improvements.

“This is a very small number of patients, so these findings can only be seen as preliminary,” says Guttuso. “Perhaps achieving higher blood levels of lithium may provide improvements to fatigue and brain fog in long COVID.”


Dosage may be too low

He notes that it is possible the randomized controlled trial was ineffective because the dose of lithium aspartate that was used was too low.

“The take-home message is that very low dose lithium aspartate, 10-15 milligrams a day, is ineffective in treating the fatigue and brain fog of long COVID,” says Guttuso. “Perhaps we need to do another randomized controlled trial that uses higher lithium aspartate dosages that achieve blood lithium levels of 0.18-0.50mmol/L to determine if they could be effective.”

An estimated 17 million people have long COVID in the U.S., and worldwide the number is estimated at 65 million.

“There currently are no evidence-based therapies for long COVID,” says Guttuso. He hopes that the National Institutes of Health will view lithium as worth studying through a trial with higher dosages; the NIH is allocating an additional $500 million to study long COVID therapies that appear to be promising.

Guttuso adds that if a subsequent randomized controlled trial finds that higher dosages of lithium aspartate are effective, long COVID patients would still need to discuss taking it with their healthcare providers; in addition, he says, if they do begin taking it at higher dosages, blood lithium levels should be monitored.

Reference: “Lithium Aspartate for Long COVID Fatigue and Cognitive Dysfunction: A Randomized Clinical Trial” by Thomas Guttuso, Jingtao Zhu and Gregory E. Wilding, 2 October 2024, JAMA Network Open.
DOI: 10.1001/jamanetworkopen.2024.36874

Co-authors with Guttuso are Gregory E. Wilding, PhD, professor, and Jingtao Zhu, research assistant, both of the Department of Biostatistics in the UB School of Public Health and Health Professions.

The UB trial was funded as a pilot project by UB’s Clinical and Translational Science Institute.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


Biomarker can help health care assess severity of COVID-19
by Karolinska Institutet
October 4, 2024

biomarker-can-help-hea.jpg

Relationship between the plasma concentration of IL-26 and severity of COVID-19. Credit: Frontiers in Immunology (2024). DOI: 10.3389/fimmu.2024.1434186

Researchers at Karolinska Institutet and the University of Gothenburg have identified a biomarker that could become an important tool for health care in assessing patients with acute COVID-19 infection. The researchers have studied interleukin (IL)-26, a signaling substance in the immune system, which has been shown to reflect the severity of the disease, viral load, and the need for hospital care.

The work is published in the journal Frontiers in Immunology.

"In our study, we have seen that immune signaling through IL-26 is closely linked to the severity of illness in COVID-19 patients," says the lead author of the study, Dr. Eduardo Cárdenas, who was affiliated with the Institute of Environmental Medicine at Karolinska Institutet at the time of the study.

Professor Anders Lindén, at the same institute, leads the research group and is a senior physician at the Karolinska Severe COPD Center, Karolinska University Hospital.

"Our new study confirms the connection between acute COVID-19 and IL-26 that we previously demonstrated in a smaller group of patients. By now examining a large and well-characterized group of patients, we have been able to show that IL-26 has the potential to become an easily accessible biomarker for quickly assessing which patients are at risk of severe disease progression, especially patients with COPD and asthma," says Lindén.

The researchers have analyzed samples from a large number of COVID-19 patients examined by Professor Magnus Gisslén's research group at the Sahlgrenska Academy, University of Gothenburg.

The results show that IL-26 levels are higher in male than in female patients, which may reflect the fact that men are more vulnerable to the infection. The IL-26 levels were also higher in patients with COPD and asthma, two patient groups that have been suspected to be sensitive to COVID-19. Overall, the IL-26 level appears to provide important information on how the immune system responds under different health conditions.

This discovery opens new ways to monitor and manage patients with acute COVID-19 in emergency care, which can contribute to faster and more personalized interventions.

The new research could lead to IL-26 being established as a routine biomarker in health care and improve the ability to predict and treat severe disease progression at an early stage.

More information: Eduardo I. Cardenas et al, Systemic increase in IL-26 is associated with severe COVID-19 and comorbid obstructive lung disease, Frontiers in Immunology (2024). DOI: 10.3389/fimmu.2024.1434186
Journal information: Frontiers in Immunology
Provided by Karolinska Institutet
 

Heliobas Disciple

TB Fanatic
(fair use applies)


COVID-19 human challenge study highlights small changes to memory and cognition
by Ryan O'Hare, Imperial College London
October 4, 2024


covid-19-human-challen.jpg

Cognition and viral load of volunteers over study period. Cognitive Scores and Viral load. A) baseline-corrected cognitive scores and B) viral load during the baseline, quarantine phase and follow-up timepoints. Upper plots show individual volunteer data, ordered within-group by mean cognitive score across all phases. Lower plots show mean data for infected (green) and uninfected (grey) groups with error bars representing the standard error of the mean. Credit: eClinicalMedicine (2024). DOI: 10.1016/j.eclinm.2024.102842

A new analysis from Imperial's human challenge study of COVID-19 has revealed subtle differences in the memory and cognition scores of healthy volunteers infected with SARS-CoV-2, which lasted up to a year after infection.

The researchers say all scores fell within expected normal ranges for healthy individuals and no one reported experiencing any lasting cognitive symptoms such as brain fog.

The findings, published in the journal eClinicalMedicine, show a small but measurable difference following highly intensive cognitive testing of 18 healthy young people with infection compared to those who did not become infected, monitored under controlled clinical conditions.

The team explains that incorporating such sensitive cognitive testing into future studies could help reveal more detailed insights into how infections may alter brain function and could help to find ways to reduce these processes when they cause symptoms.

Senior author Professor Adam Hampshire, from the Department of Brain Sciences at Imperial College London and now based at King's College London, explained, "We know that COVID-19 can have lasting impacts on our memory and ability to carry out common cognitive tasks. However, much of the scientific evidence we have comes from large studies based on self-testing and reporting, or where there's a range of variables that could increase or reduce these effects.

"Our work shows that these cognitive effects are replicated even under carefully controlled conditions in healthy individuals—including infection with a comparable dose of virus—and further highlights how respiratory infections can impact specific aspects of brain function.

"We were only able to detect some of these effects because of the trial design, which used very sensitive tests and controlled conditions, with participant performance compared to their own pre-inoculation baselines. This enabled us to pick up on subtle changes of which the participants themselves appear not to have been aware."


COVID-19 and cognition

Previous studies that included patients with a wide range of severities have shown COVID-19 can have a lasting impact on people's brain function. One such study, led by Imperial and involving more than 140,000 people, found small deficits in the performance of cognitive and memory tasks in people who had recovered from COVID-19, with differences evident a year or more after infection.

In the latest study, researchers analyzed findings from a small group of healthy volunteers who were part of the world's first human challenge study for COVID-19 in 2021. The findings reveal subtle differences in how they performed on the same tests, which lasted up to 12 months although later testing could have been affected by other and later factors.

During the trial, 36 healthy, young participants with no previous immunity to the virus were infected with SARS-CoV-2 and monitored under controlled clinical conditions. They were carefully monitored and remained at the facility until they were no longer infectious. From the group, 18 participants became infected and developed mild illness, one without symptoms.

Participants also performed sets of tasks to measure multiple distinct aspects of their brain function, including memory, planning, language and problem solving, using the Cognitron platform. Participants took the tests before exposure to the virus, during the two weeks they spent in the clinical facility, and then at multiple points for up to a year.

Analysis showed that those who became infected with SARS-CoV-2 had statistically lower cognitive scores than uninfected volunteers—compared to baseline scores—during their infection as well as during the follow-up period. The main differences in scores were seen in memory and executive function tasks (including working memory, attention and problem solving).

Differences in scores between groups were seen up to one year after infection, with the uninfected group performing slightly better on tasks overall.

The researchers note that the observed differences were small and that none of the volunteers reported prolonged cognitive symptoms. They also highlight limitations of the study, including the small sample size and that the majority of participants were white males, and so caution is needed in extrapolating the findings to the general population.

They explain that future research could examine the biological links between respiratory infection and cognition in COVID-19, and even show how this impact compares with other conditions, such as Respiratory syncytial virus (RSV) or influenza.

Co-author Professor Christopher Chiu, from the Department of Infectious Disease at Imperial College London, who led the COVID-19 human challenge study, said, "These latest findings from our study add more fine detail to the picture we have of COVID-19 and other respiratory infectious diseases.

"Challenge studies can offer a tool to help us better understand how infections disrupt a range of biological functions. Here, by showing biological effects that fall below what could be considered symptoms or disease, we were able to identify the smallest changes in these pathways.

"This could ultimately help us to develop new treatments to reduce or even block some of these effects, which we know on other settings can have lasting impacts on people's lives."

More information: William Trender et al, Changes in memory and cognition during the SARS-CoV-2 human challenge study, eClinicalMedicine (2024). DOI: 10.1016/j.eclinm.2024.102842
Journal information: EClinicalMedicine
Provided by Imperial College London
 

Heliobas Disciple

TB Fanatic
(fair use applies)


EXPOSED!: Secret WAR Against Early Covid Treatment
Dr Peter McCollough: A Personal Reflection on Courage, Science, and the Fight for Medical Truth

Dr Philip McMillan
Oct 05, 2024

Today, I want to share an extraordinary conversation I had with Dr. Peter McCullough, a figure who has been both praised and vilified during the pandemic. I first met him at a conference in Canada, and the experience was remarkable. Here was a man who had weathered unimaginable attacks from all sides, yet remained steadfast in his mission to advocate for balanced, evidence-based medicine throughout the COVID crisis. His perseverance and commitment to truth make him a voice worth listening to.

Dr. McCullough's story is both inspiring and sobering. A renowned cardiologist and internal medicine expert with decades of experience, he found himself in the eye of the storm when the pandemic hit. He was one of the first to ask critical questions about how we were handling COVID-19. As task forces were formed to protect healthcare workers, Dr. McCullough was already thinking about the patients: How would we treat them? How would we help them avoid hospitalization and death?

It was this question that led him to develop the now-famous McCullough Protocol, an early treatment regimen that could have altered the course of the pandemic. But instead of being welcomed by the medical community, Dr. McCullough faced unprecedented pushback. Despite having the evidence, the push for early treatment was sidelined in favor of a singular narrative: wait for the vaccine.

What stood out to me in our conversation was the immense personal cost Dr. McCullough endured. He lost not one but two jobs, was publicly defamed, and had his medical credentials attacked. Yet, through it all, he never backed down. Why? Because he believed that patients deserved better. He knew that early treatment could save lives, and he was willing to stand up for that truth, no matter the consequences.

In today's world, where science often seems secondary to agendas, Dr. McCullough's courage is a rare and valuable trait. His story is not just about COVID-19—it's about the integrity of medicine itself. He reminds us that the true role of a doctor is to be an advocate for patients, not a mouthpiece for the status quo.

As we continue to navigate this evolving pandemic, I invite you to reflect on the lessons Dr. McCullough has shared. His journey is a reminder that, even in the face of overwhelming opposition, truth and science must prevail.



59 min 48 sec

View: https://www.youtube.com/watch?v=ObCWPkQW-d0


Timecodes


00:02 - Meeting Dr. Peter McCullough at a conference in Canada
01:19 - Dr. McCullough’s background in cardiology and internal medicine
05:44 - How Dr. McCullough got involved in the COVID-19 response
06:33 - Questioning the lack of treatment protocols for patients
09:23 - The creation of the McCullough Protocol for early treatment
16:17 - Pushback from the medical community against early treatment
19:03 - The prevailing "wait for the vaccine" narrative
30:02 - Losing the first job due to advocating early treatment
32:28 - Personal and professional consequences for Dr. McCullough
36:18 - Losing the second job after gaining media attention
37:00 - Public defamation and being labeled one of the "worst doctors"
39:03 - Attacks on his medical credentials and licensing
40:07 - The importance of standing up for patient advocacy
41:16 - Doctors resisting stepping out of the medical establishment’s line
44:07 - The role of propaganda in suppressing dissent in medicine
47:04 - The rise of long COVID and vaccine injury syndromes
 

Heliobas Disciple

TB Fanatic
(fair use applies)


COVID-19 Infections Rising in France

Nikhil Prasad Fact checked by:Thailand Medical News Team
Oct 05, 2024

France is witnessing a notable increase in COVID-19 infections as the latest data reveals a steady upward trend in cases across the country. Public health authorities are closely monitoring the situation, with concerns heightened as the virus's circulation intensifies, particularly among older adults. This Medical News report will explore the current state of COVID-19 in France, emphasizing the importance of preventive measures, vaccinations, and the research behind these findings.


COVID-19 Cases on the Rise

In the week of September 16-22, 2024 (Week 38), the latest report from Santé Publique France highlights a worrying rise in COVID-19 indicators. The report shows an increase in COVID-19 activity both in hospitals and in general medical practice across all age groups, with adults, particularly those over 65 years old, being the most affected.

For the fourth consecutive week, France’s wastewater surveillance system, which detects the presence of SARS-CoV-2 in sewage, has shown a rise in viral concentration. This trend suggests that the virus is spreading more widely, and experts warn that this could be the beginning of a larger wave of infections. Close monitoring will be essential over the coming weeks to assess the full extent of this resurgence.


Key Indicators of the Current Situation
Several important indicators have increased in recent weeks, showing a clear uptick in COVID-19 activity:

-Medical Visits: During Week 38, 4% of all SOS Médecins (emergency medical services) consultations were for suspected COVID-19 cases, up from 2.8% in Week 37. The increase was particularly pronounced among adults aged 65 and older, with 4.8% of medical visits in this group being for suspected COVID-19, compared to 2.6% the previous week. Younger age groups, including children aged 5-14, also saw slight increases in suspected COVID-19 consultations.

-Hospital Visits: Hospital emergency room visits for suspected COVID-19 also rose, with 0.9% of all ER visits being related to COVID-19 in Week 38, up from 0.6% the previous week. Of these cases, 1.8% resulted in hospitalizations, marking a significant jump from the previous week’s 1.1%.

-Testing Positivity: COVID-19 testing data also indicates a rising trend, with the positivity rate for tests conducted in medical labs increasing to 29% in Week 38 from 24.3% in Week 37. In hospital settings, the positivity rate grew to 15.3% from 12.6%.

These indicators, along with wastewater data, paint a concerning picture of the virus’s continued spread. The rise in COVID-19 cases appears to be driven by a combination of factors, including increased transmission in the community and waning immunity among older populations.


The Importance of Preventive Measures
Even with the ongoing vaccination efforts, public health authorities stress that preventive measures remain crucial in curbing the spread of COVID-19. Simple actions, such as wearing a mask in crowded places and practicing regular hand hygiene, can significantly reduce the risk of transmission. For individuals experiencing symptoms of respiratory illness, staying home and avoiding contact with others is essential to prevent further spread, particularly to vulnerable groups such as the elderly and those with weakened immune systems.

The rise in cases serves as a reminder that COVID-19 is still a threat, and vigilance is required to avoid another widespread outbreak. Public health experts are urging the public to continue following recommended guidelines to protect themselves and those around them.


Virological Surveillance and the Dominance of the JN.1 Variant

The virological surveillance data from Santé Publique France also sheds light on the variants of the virus currently circulating in the country. The JN.1 variant has become the dominant strain in France, accounting for over 99% of the sequences analyzed during the most recent Flash Survey conducted on September 2, 2024. This variant, along with its sublineages, has been driving the recent increase in cases.

Among the sublineages of JN.1, the KP.3.1.1 variant has seen a particularly rapid rise in prevalence, representing 67% of the sequences in the latest survey. Other sublineages are also circulating, but KP.3.1.1 is currently the most widespread. Ongoing genomic surveillance will be crucial in tracking the evolution of these variants and understanding their impact on the spread of the virus.


The Role of Wastewater Surveillance
One of the key tools used to monitor the spread of COVID-19 in France is wastewater surveillance. This method, which involves testing sewage for traces of the virus, provides a reliable early warning system for detecting increases in viral circulation. In Week 38, all 12 wastewater treatment plants monitored in France reported rising levels of SARS-CoV-2, with viral concentrations increasing by 36.3% compared to the previous week.

Wastewater surveillance has proven to be a valuable indicator of COVID-19 trends, often detecting rises in cases before they are reflected in clinical data. This allows public health officials to respond more quickly to emerging outbreaks and take necessary preventive actions.


Conclusion: A Call for Continued Vigilance

As COVID-19 infections continue to rise in France, particularly among older adults, the importance of preventive measures and vaccinations cannot be overstated. The current increase in cases is a stark reminder that the virus is still circulating and poses a risk to vulnerable populations. With the JN.1 variant dominating the landscape and its sublineages on the rise, ongoing surveillance and public health efforts will be critical in managing the spread of the virus.

As the situation evolves, public health authorities will be closely monitoring the data to ensure that appropriate actions are taken to protect the population.

In conclusion, while the rise in cases is concerning, there are steps that can be taken to mitigate the impact of the virus. By remaining vigilant, following public health guidelines, France can continue to manage the ongoing COVID-19 challenge.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


Does Vitamin C Help in the Fight Against COVID-19?
Nikhil Prasad Fact checked by:Thailand Medical News Team
Oct 06, 2024

The COVID-19 pandemic has led researchers across the world to explore various treatments that could potentially help reduce the severity of the disease. One such potential treatment is Vitamin C. This essential nutrient, commonly used to boost the immune system, has been investigated for its effects on patients hospitalized with COVID-19. A recent study explored whether Vitamin C could lower the risk of in-hospital death and shorten the length of time spent in the Intensive Care Unit (ICU). This Medical News report delves into the findings of this comprehensive study, which involved multiple trials across different countries and patients, shedding light on the true impact of Vitamin C supplementation on COVID-19 outcomes.


Why Vitamin C?

Since the beginning of the pandemic, many medical professionals and researchers have been interested in Vitamin C due to its immune-boosting properties. Vitamin C has long been used to help fight off infections and promote healing. With the global crisis brought on by COVID-19, some researchers speculated that it might also help improve outcomes for COVID-19 patients. The study focuses on the outcomes of patients who were given Vitamin C as part of their treatment compared to those who were not. These outcomes included mortality rates, the length of ICU stays, and any adverse events experienced by the patients.


The Study Setup
Researchers from various institutions, including the Center for Evidence-Based Medicine at Chengdu University, West China Hospital, conducted a systematic review and meta-analysis of studies that focused on the effects of Vitamin C supplementation in COVID-19 patients. The research team searched multiple databases, including PubMed and Cochrane Central, for randomized controlled trials (RCTs) that compared Vitamin C supplementation with standard treatments. After a thorough review, they included 11 clinical trials in their analysis, encompassing thousands of patients from different countries.

These studies focused on hospitalized patients diagnosed with COVID-19 and primarily aimed to evaluate whether Vitamin C could reduce the risk of death during hospital stays. Secondary outcomes, such as the length of time patients spent in the ICU or in the hospital, were also examined.


Key Findings: Mortality and ICU Stay

One of the primary outcomes examined was the in-hospital mortality rate among COVID-19 patients who received Vitamin C supplementation. However, after reviewing the results from the 11 clinical trials, the researchers concluded that Vitamin C did not significantly reduce the risk of death. The mortality rate for patients who received Vitamin C was not much different from those who received standard treatments without the vitamin.

Additionally, the length of time spent in the ICU was analyzed. The study found that patients who were given Vitamin C did not experience shorter ICU stays compared to those who received standard care. This finding was consistent across most of the trials included in the analysis. Ther e was no significant difference in the length of hospital stay either, indicating that Vitamin C does not appear to speed up recovery time for COVID-19 patients.


No Major Differences in Adverse Events

Another important aspect of this study was the assessment of adverse events. Adverse events refer to negative side effects or complications that may arise during treatment. The researchers found that there was no major difference in adverse events between the patients who received Vitamin C and those who did not. Both groups experienced similar rates of complications, indicating that Vitamin C supplementation is generally safe for patients with COVID-19, though it did not offer additional benefits in terms of reducing complications or adverse outcomes.


Limitations of the Study

While the study provided valuable insights into the effects of Vitamin C on COVID-19 patients, there were some limitations. The sample size of some trials was relatively small, and the overall number of studies available for analysis was limited. This could affect the strength and generalizability of the conclusions. Additionally, the dosage and duration of Vitamin C treatment varied across the studies, which could have influenced the results.

It's also worth noting that COVID-19 treatment standards have evolved over time as more has been learned about the disease. This variation in treatment practices across different countries and hospitals may have influenced the outcomes of the trials, making it harder to draw firm conclusions about the effectiveness of Vitamin C in isolation.


Conclusion

The study findings provide a clear perspective on the role of Vitamin C in treating COVID-19 patients. Based on the findings, Vitamin C supplementation does not significantly reduce in-hospital mortality rates or shorten the length of ICU stays for patients with COVID-19. While the vitamin remains a safe supplement for these patients, it does not appear to provide the additional benefits that many had hoped for at the beginning of the pandemic.

The study's conclusions are based on the best available evidence from randomized controlled trials, the gold standard in medical research. However, due to the limitations of the study, including the small sample sizes and variability in treatment protocols, further research is needed. Future studies should focus on larger patient groups and standardized treatment protocols to provide more definitive answers about the role of Vitamin C in COVID-19 treatment.

The study findings were published in the peer-reviewed journal: Frontiers in Nutrition.

 

Heliobas Disciple

TB Fanatic
(fair use applies)


Ultra-powered MRI scans show damage to brain's 'control center' is behind long-lasting COVID-19 symptoms
by University of Cambridge
October 7, 2024

Damage to the brainstem—the brain's 'control center'—is behind long-lasting physical and psychiatric effects of severe COVID-19 infection, a study suggests.

Using ultra-high-resolution scanners that can see the living brain in fine detail, researchers from the Universities of Cambridge and Oxford were able to observe the damaging effects COVID-19 can have on the brain.

The study team scanned the brains of 30 people who had been admitted to hospital with severe COVID-19 early in the pandemic, before vaccines were available. The researchers found that COVID-19 infection damages the region of the brainstem associated with breathlessness, fatigue and anxiety.

The powerful MRI scanners used for the study, known as 7-Tesla or 7T scanners, can measure inflammation in the brain. Their results, published in the journal Brain, will help scientists and clinicians understand the long-term effects of COVID-19 on the brain and the rest of the body. Although the study was started before the long-term effects of COVID were recognized, it will help to better understand this condition.

The brainstem, which connects the brain to the spinal cord, is the control center for many basic life functions and reflexes. Clusters of nerve cells in the brainstem, known as nuclei, are responsible for regulating and processing essential bodily functions such as breathing, heart rate, pain and blood pressure.

"Things happening in and around the brainstem are vital for quality of life, but it had been impossible to scan the inflammation of the brainstem nuclei in living people, because of their tiny size and difficult position." said first author Dr. Catarina Rua, from the Department of Clinical Neurosciences. "Usually, scientists only get a good look at the brainstem during post-mortem examinations."

"The brainstem is the critical junction box between our conscious selves and what is happening in our bodies," said Professor James Rowe, also from the Department of Clinical Neurosciences, who co-led the research. "The ability to see and understand how the brainstem changes in response to COVID-19 will help explain and treat the long term effects more effectively."

In the early days of the COVID-19 pandemic, before effective vaccines were available, post-mortem studies of patients who had died from severe COVID-19 infections showed changes in their brainstems, including inflammation. Many of these changes were thought to result from a post-infection immune response, rather than direct virus invasion of the brain.

"People who were very sick early in the pandemic showed long-lasting brain changes, likely caused by an immune response to the virus. But measuring that immune response is difficult in living people," said Rowe. "Normal hospital type MRI scanners can't see inside the brain with the kind of chemical and physical detail we need."

"But with 7T scanners, we can now measure these details. The active immune cells interfere with the ultra-high magnetic field, so that we're able to detect how they are behaving," said Rua. "Cambridge was special because we were able to scan even the sickest and infectious patients, early in the pandemic."

Many of the patients admitted to hospital early in the pandemic reported fatigue, breathlessness and chest pain as troubling long-lasting symptoms. The researchers hypothesized these symptoms were in part the result of damage to key brainstem nuclei, damage which persists long after COVID-19 infection has passed.

The researchers saw that multiple regions of the brainstem, in particular the medulla oblongata, pons and midbrain, showed abnormalities consistent with a neuroinflammatory response. The abnormalities appeared several weeks after hospital admission, and in regions of the brain responsible for controlling breathing.

"The fact that we see abnormalities in the parts of the brain associated with breathing strongly suggests that long-lasting symptoms are an effect of inflammation in the brainstem following COVID-19 infection," said Rua. "These effects are over and above the effects of age and gender, and are more pronounced in those who had had severe COVID-19."

In addition to the physical effects of COVID-19, the 7T scanners provided evidence of some of the psychiatric effects of the disease. The brainstem monitors breathlessness, as well as fatigue and anxiety. "Mental health is intimately connected to brain health, and patients with the most marked immune response also showed higher levels of depression and anxiety," said Rowe.

"Changes in the brainstem caused by COVID-19 infection could also lead to poor mental health outcomes, because of the tight connection between physical and mental health."

The researchers say the results could aid in the understanding of other conditions associated with inflammation of the brainstem, like MS and dementia. The 7T scanners could also be used to monitor the effectiveness of different treatments for brain diseases.

"This was an incredible collaboration, right at the peak of the pandemic, when testing was very difficult, and I was amazed how well the 7T scanners worked," said Rua. "I was really impressed with how, in the heat of the moment, the collaboration between lots of different researchers came together so effectively."

More information: Catarina Rua et al, Quantitative susceptibility mapping at 7 T in COVID-19: brainstem effects and outcome associations, Brain (2024). DOI: 10.1093/brain/awae215
Journal information: Brain
Provided by University of Cambridge
 

Zoner

Veteran Member

FDA halts Novavax's vaccine trials after safety scare​

The U.S. Food and Drug Administration (FDA) has suspended Novavax's experimental combined COVID-19 and flu vaccine clinical trials. This decision followed reports of a participant's symptoms of nervous system damage, and the stock market has reacted to these reports.
The vaccine, expected to be groundbreaking due to its simultaneous protection against COVID and flu, may face delays. Novavax disclosed that a participant in the mid-stage clinical trial experienced symptoms of motor neuropathy last month. This condition involves damage to the nerve cells responsible for muscle control and movement. However, the company emphasizes that no certainty exists that the vaccine caused these symptoms. (yeah right...smh)

"Our goal is to resolve this issue successfully and start the phase three trial as soon as possible," said Robert Walker, Chief Medical Officer of Novavax, as quoted by Reuters. The company notes that other COVID-19 and flu vaccine studies have shown no safety signals linked to motor neuropathy.
 

Heliobas Disciple

TB Fanatic
I was gone for the hurricane. All is well, it wasn't an Ian situation thank the Lord. Lost power for a day, internet for a few days more, but no damage. Anyway, way too many articles to post them in full so as a hurricane exception, I will just post the links for the days I was absent and will carry on from the present time.
























 

Heliobas Disciple

TB Fanatic
(fair use applies)


COVID-19 XEC variant is now circulating in the US. Here's what you should know about it.
Ahjané Forbes, USA TODAY
Tue, October 15, 2024, 4:12 PM EDT

KP.3.1.1 is still the dominant COVID-19 variant in the United States as it accounts for nearly 60% of positive cases, but the XEC variant is not far behind, recent Centers for Disease Control and Prevention (CDC) data shows.

"CDC is monitoring the XEC variant," Rosa Norman, a CDC spokesperson told USA TODAY. "XEC is the proposed name of a recombinant, or hybrid, of the closely related Omicron lineages KS.1.1 and KP.3.3."

The variant, which first appeared in Berlin in late June, has increasingly seen hundreds of cases in Germany, France, Denmark and Netherlands, according to a report by Australia-based data integration specialist Mike Honey.

The CDC's Nowcast data tracker, which displays COVID-19 estimates and projections for two-week periods, reflected that the KP.3.1.1 variant accounted for 57.2% of positive infections, followed by XEC at 10.7% in the two-week stretch starting on Sept. 29 and ending on Oct. 12.

KP.3.1.1 first became the leading variant between July 21 and Aug. 3.

The latest data shows a rise in each variant's percentage of total cases from Sept. 15-28, as KP.3.1.1 rose by 4.6%, and XEC rose by 5.4%. Previously, the KP.3.1.1 variant made up 52.6% of cases and XEC accounted for 5.3% from Sept. 15-28.

Here is what you need to know about the XEC variant and the latest CDC data.

COVID-19: Your free COVID-19 at-home tests from the government are set to expire soon. Here's why.
What are the most dominant variants that are circulating the United States?

The CDC's Nowcast data tracker shows that the following strains are in the top 10 of most dominant variant proportions:

Can't see the table? Click here to view it

[...]
 

Zoner

Veteran Member
I was gone for the hurricane. All is well, it wasn't an Ian situation thank the Lord. Lost power for a day, internet for a few days more, but no damage. Anyway, way too many articles to post them in full so as a hurricane exception, I will just post the links for the days I was absent and will carry on from the present time.
























Glad you made it thru the storm safely.
This is quite the summary of news. But we hear nothing about these things these days. Just election election election.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


Rising Levels of Chronic Illness in Children from SARS2
Radagast
October 19, 2024

I’ve written before about how we’re seeing signs of widespread brain damage in children. I don’t really like reporting on these things much. I would rather just post about more pleasant stuff. But the whole world now insists on pretending that none of this is going on, so I feel obliged to point out the problem to people who notice something’s wrong.

So, if long Covid was some kind of invention of hysterical cat ladies, as some like to think, then it’s pretty obvious what should happen. As time goes by, the number of cases should go down again. But have a look at what we actually see in children:

1longcovidgrowth-866x1024.jpg


This is a doubling in the number of children with long COVID symptoms, between march 2023 and march 2024, a period in which everyone has started treating this virus like ancient history. How many doublings like this do you think we can afford to have until we’re left with nobody to keep the power plants running and the shelves in the supermarket filled?

The evidence is just clear: Something went wrong and it’s gradually getting worse. That’s why we see growing numbers of two year olds who can’t talk, growing numbers of kids who go to kindergarten with developmental impairment and growing numbers of children with long COVID. If the situation was stable I would move on to other stuff, but you’re dealing with a problem that’s steadily getting worse.

I’m going to point out again, that this is all a consequence of mass vaccination. My hope is that as the children now start to get chronically ill in droves, people will start asking themselves what went wrong, which means something can be done about it.

Almost all transmission is caused by obese elderly, this has been well studied, they exhale large amounts of aerosols. This causes healthy unvaccinated young people to suffer constant immune activation, which is particularly damaging for children. The immunological freeloading of the vaccinated places a high burden on the unvaccinated, particularly children.

We know why these vaccinated people constantly keep getting reinfected: They’re now stuck with a poor immune response against this virus. Most deaths in 2020 were caused by a very aggressive immune response to the virus.
Vaccinate people and you will tone down that immune response, so fewer people will die initially, although the virus will return with a vengeance.

These waves continue to cause piles of deaths too, this week we have another spike in all age groups, 427 people in the Netherlands who died in excess. Here you have the number for all the past years:

1cbssterfte.jpg


These numbers are now stuck at about 15% above normal. The government is saving hundreds of millions of euros every year, because every year this country now has tens of thousands of excess deaths. But nobody is demanding answers, as to what’s going on. You don’t have to die to suffer the consequences of this problem, you could suffer a stroke or or develop long COVID.

If the problem was gone, if excess mortality returned to normal, the children stopped showing brain damage, there was no growth in long COVID cases, there were no waves of this virus in the middle of summer, there was no evidence of steadily growing virulence, we didn’t have an increase in strokes in young adults anymore and we didn’t see a bunch of new glycans emerge in the NTD, I would accept that I’m wrong and shut up about it.

But that’s not happening. How am I supposed to shut up about a problem everyone ignores, that’s killing 300 people every week, just in my country alone? If they died because they ate cheeseburgers, if they died because they didn’t wear a seatbelt, I would ignore it. But they die because they’re being deceived. And it’s a canary in the coalmine, for what is to come.

I’ve spent so much effort, explaining and demonstrating how the immune response has been impoverished. I’ve documented all this stuff, how people were left with enhancing antibodies that new variants of the virus continued to recall, without recalling the neutralizing antibodies. I’ve documented how the innate immune response is interfered with. I’ve documented how we’ve seen a class switch towards IgG4 and IgG2 against the receptor binding domain, which are not suited for neutralization at all. I’ve also documented the original antigenic sin problem, droves of people are just not able to develop a novel potently neutralizing antibody response.

And hey, everyone is just fine with the excess mortality apparently. But I don’t like it that we now have droves of children stuck with damaged bodies.

By now you should already know how it’s going to end: It’s going to end with a swarm of variants that are simply not affected by the antibodies anymore, mostly as a result of new N-linked glycans in the N-Terminal Domain of the Spike protein. That’s how the immunological freeloading that was achieved by some of the population comes to an end.
Well, that’s what’s happening. You had the summer wave, with variants that deleted S:31 to put a glycan on S:30. Now we mostly get variants that turn S:22 to Asparagine (N), to put a glycan on S:22 instead of S:30. That’s what “XEC” does among others.

But they’re already adding the next glycan on top: You now have a wave that turns 190 into Serine, which puts a glycan on 188. Some go for Threonine at 190, but that looks like a dead-end strategy. It demonstrates however how strong the pressure now is to add all these glycans on the NTD.

If you turn S:22 to Aspargine, turn S:190 to Serine and add S:A475V, which has independently been shown to be very fit, you get a variant with a big 108% growth advantage.

What you’re witnessing is this virus complete its glycan shield. Numerous viruses have such a glycan shield, that allows them to survive despite an antibody response in the host.

The point I’m making here is that you can just see the process, the birth of a proper glycan shield, happen in real time now: You can see all these glycans being added, which leaves you with a virus against which the antibodies won’t work. Because the T cell epitopes will be physically blocked by these glycans, the B cells won’t even be stimulated by CD4+ T cells to produce the antibodies anymore.

Nobody really disputes that there is now strong convergent pressure to add N-linked glycans to the N-Terminal Domain. But ask yourself: Why would a virus like this suddenly start adding N-linked glycans to its N-Terminal Domain? Why would there suddenly be a fitness advantage for such changes now, that wasn’t there two or three years ago?
The answer is straightforward: Neutralization now depends on antibodies against the N-Terminal Domain. That’s not how it’s supposed to work, it’s supposed to be IgG3 antibodies against the Receptor Binding Domain, but you already know what happened to those, they underwent a class switch.

The immune system developed a compensatory response, a strong antibody response against the N-Terminal Domain. The virus is now evolving to avoid that abnormal compensatory response. This is relatively easy, because the N-Terminal Domain is under less constraints than the Receptor Binding Domain anyway.

Most important perhaps is to note that none of this has to be perfect. We don’t know where the threshold lies and it’s likely to differ to some degree between individuals. SARS-COV-2 is capable of exhausting T cells, unlike other respiratory viruses. So when things get sufficiently nasty, there are feedback loops like this that start to accelerate the problem. Exhausted or senescent CD4+ T cells won’t stimulate the B cells, which then won’t go on to become antibody producing plasma cells.

The underlying problem of course, is that vaccination resulted in abnormally high concentrations of antibodies, fifty times higher than after a natural infection after just two shots. That’s what broke everything. These antibodies will interfere in the ability of the innate immune system to properly perform its job and improve its performance over time (training of innate immunity). They interfere in the ability of NK cells to learn to recognize the virus through their natural cytotoxicity receptors, interfere in plasmacytoid dendritic cells detecting the virus and interfere in monocytes migrating into different tissues, where they can mature into macrophages or dendritic cells.

You might wonder: If glycans allow the virus to avoid antibodies, why doesn’t every respiratory virus just develop a bunch of glycans that make the antibody response useless? Because there is a trade-off. Glycans can make it easier for the innate immune system to recognize a virus:
While N-linked glycans can contribute to neutralizing antibody epitopes, particularly in HIV,11 their main effect as large, immunologically “self” structures is to occlude the underlying protein surface. This means that changes in the glycan shield, with respect to the position of an N-linked glycan site and the processing state of the attached glycan, can modulate viral infectivity and hamper vaccine design efforts.12,13 Conversely, the presence of underprocessed glycans on viral glycoprotein immunogens, particularly of the oligomannose type, can enhance the interaction with the innate immune system and assist trafficking to germinal centers.14
At first, the response to these abnormally high vaccination induced antibodies is to mutate to avoid them. This then results in more recruitment of T cells and somatic hypermutation, to broaden the adaptive immune response to a wider range of epitopes, including increasing the response to the NTD.

Eventually, there is a class shift seen in the antibodies, to IgG2 and IgG4. This has now been documented for the mRNA and the Chinese inactivated vaccines, so it’s a problem that affects most of the global population. This class shift results in increasing undermining of the innate immune system. Before the class shift, NK cells can still recognize infected cells thanks to the antibodies. Such a response takes time, it’s slower compared to the cytotoxicity receptors they would normally use. After the class shift from IgG3 to IgG2 and IgG4 takes place however, the antibodies tell the NK cells to ignored the infected cells. NK cells can also be directly damaged, by the numerous breakthrough infections.

The result of all of this is that the innate immune system of most of the population is now undermined. It’s not just the case that people’s innate immune system failed to train against SARS2, it has been weakened by numerous breakthrough infections and high concentrations of IgG2 and IgG4 antibodies.

You can see signs of this from various lines of evidence, including the record levels of pneumonia observed in the population during winter:

1pneumonia-2.jpg


Eventually the strategy of antibody evasion ceases to work for this virus, because people end up with very high concentrations of antibodies against a wide range of epitopes. That’s when the virus becomes forced to resort to adding new glycans to continue to spread. That’s where we’re now at. The added glycans we now see only emerge once the virus is under very strong pressure from the antibody response against the NTD, with no opportunity to evade those antibodies through simple mutation.

It’s not normal for the population to fail to develop lasting immunity against this virus and for this virus to display an unseasonal pattern. It disappeared throughout Europe in the summer of 2020, but since then it has caused waves of infections every summer. That’s a consequence of the adaptive immune system being forced to handle this virus on its own. France has just had the worst summer wave so far.

This is of course the exact opposite of what you would expect from a virus becoming endemic. If the virus is supposed to behave like another hCov, it’s supposed to settle into a normal seasonal pattern. This is not a problem that just solves itself over time, rather, it’s a problem that grows worse over time, as the antibody response gradually broadens to target less immunogenic epitopes. If you don’t solve this, the virus will solve it in its own way.

As long as the immunological freeloading by a share of the population continues, we place very high demands on the innate immune system of children exposed to these vaccinated people, whose immune systems are unable to control the virus. The closest thing I’ve seen to a solution is to administer high doses of cannabinoids, which discourage production of antibodies and force the innate immune system to take over. But this hasn’t been studied in relation to SARS2, so we don’t yet know if it works. I have been pointing out this problem multiple times now, but unfortunately nobody is interested in working on a solution.
 

Heliobas Disciple

TB Fanatic
John Campbell did two back to back videos about this subject and then linked to the substack article about the study he's discussing. I will post the videos here and the article in the next post.

View: https://www.youtube.com/watch?v=p-qU6jq8wv8
Proof, DNA contamination report
Dr. John Campbell
Oct 18, 2024
21 min 35 sec

Summary of my interview with analytical virologist Dr. David J. Speicher


View: https://www.youtube.com/watch?v=FuIUDh-DtQ4
DNA in RNA vaccines
Dr. John Campbell
Oct 19, 2024
1 hr 41 sec

Summary of my interview with analytical virologist Dr. David J. Speicher
 

Heliobas Disciple

TB Fanatic
(fair use applies)


DNA fragments detected in monovalent and bivalent Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario, Canada
Investigation into 8 Pfizer and 19 Moderna modified RNA COVID-19 vaccines from 12 unique lots, including the newly released Moderna Spikevax monovalent XBB.1.5 booster

Dr. David Speicher
Courageous Truth
Oct 19, 2023


For if you remain silent at this time, relief and deliverance for the Jews will arise from another place, but you and your father’s family will perish. And who knows but that you have come to your royal position for such a time as this? - Esther 4:14

We all have struggles. Those who know me well know that I have had a severe stutter since I was a child and that I have often been teased and discriminated against for my stutter and faith, but I have never been one to back down from disseminating the truth. In Grade 12, I had a high school guidance counselor tell me to never attempt university because I would never make it in life. Sure, it hurt to hear those words, but it did not deter me. I was inspired and completed an MSc (Hons) in Clinical Microbiology and a PhD in Virology from Griffith University (Queensland Australia) and have been an integral part of cutting-edge research in Australia, Kenya, India, and Canada.

Many of us have heard of the problems with the COVID vaccines including the biodistribution issues and increased rates of myocarditis. As a virologist and colleague of many of the heroes, like Drs. Byram Bridle and Pierre Kory, I have often thought about my role in the pandemic. Over the past several months I have collaborated with Kevin McKernan, Dr. Jessica Rose, Dr. Maria Gutschi, and Dr. David Wiseman to investigate the levels of residual DNA in 8 Pfizer and 19 Moderna modified RNA COVID-19 vaccines from 12 unique lots, including the newly released Moderna Spikevax monovalent XBB.1.5 booster. Using VAERS data we were able to perform some exploratory analysis comparing residual DNA loads to adverse events and serious adverse events.

Our key findings are as follows:
  1. Residual plasmid DNA from Process 2 manufacturing is found in all Pfizer and Moderna COVID-19 vaccines as high as 4.27 ng/dose.
  2. Using Qubit fluorometry the residual plasmid DNA is as high as 5,100 ng/dose equating to 188 – 509-fold excess of the FDA and WHO 10 ng/dose guidelines.
  3. Pfizer contained more amplifiable DNA than Moderna and all Pfizer contain the SV40 promoter-enhancer-ori.
  4. A positive dose-response relationship was observed for the Pfizer lots based on qPCR estimation of residual DNA.
  5. The most recent Moderna XBB.1.5 vaccine contained similar levels as other Moderna lots suggesting that DNA residues have not been reduced and remains an issue.
This work highlights the need for regulators and industry to adhere to the precautionary principle, to provide sufficient and transparent evidence that products are safe and effective, and to disclose the details of their composition and method of manufacture.

The full preprint manuscript can be read here.

 

Heliobas Disciple

TB Fanatic
Radagast has the same message as Geert, but unlike Geert, he's still posting. Geert was talking about glycans as the method for the Geert variant to evolve a few years ago. Radagast talks about it too. If it wasn't for his abrasvie personality, I'd suspect they were the same person :D. But they aren't - they do agree on the immunity problems from covid and the vaccines though. But probably nothing else!


(fair use applies)


What stops the population from developing herd immunity to SARS2?
Radagast
October 20, 2024

There are a number of reasons why I correctly anticipated back in march 2020 that SARS2 would prove to be less deadly than people expected. To start with, I anticipated that the number of people already infected would be underestimated, because a lot would have such a mild infection, they never developed any antibodies passing the threshold at which we can measure them. That turned out to be correct, about half of people with a clear T-cell response did not have an accompanying antibody response.

In addition, I anticipated that the people who were first to be infected, would in general be in worse health on average than those who did not immediately get infected. This was also correct. It’s now clear that obese people are more likely to be infected. In addition, elderly people more easily got infected. Children were apparently not able to be infected by the first variants at all, it required the virus to mutate.

There were other issues at the time, patients were being placed on respirators who were still talking, to protect medical personnel from “aerosolizing procedures”. This creates a huge risk of deadly bacterial superinfections for those patients. A certain Meredith in New York City admitted this, but after realizing what she admitted, she disappeared off Twitter. In addition, the first places to have massive numbers of infections were dense cities, where air pollution is very high, like in New York City and Northern Italy.

What I did not anticipate at the time, is that people would practice mass vaccination against this virus. And the thing about science, is that it doesn’t care about your feelings. For the past four years I have run into this general pattern: People from various substacks show up here and insist that although I’m right about SARS-COV-2, I fell for the “global warming hoax”.

But I don’t make the rules: Increase the carbon dioxide content in our atmosphere at the fastest pace seen in tens of millions of years and you start causing massive trouble. I could come up with arguments for why you’ll be fine when you jump out of your thirteenth floor apartment too, but coming up with arguments won’t change the actual outcome, which is mostly going to be a product of physics.

Well, vaccination against this virus, is another sort of intervention that ends up causing massive trouble after a while, because viruses evolve. This was immediately obvious to me at the time. We have immune systems that are very complex and we started intervening in what they do, without understanding what the consequences could be.

Increasing the antibody concentrations with vaccines to fifty times normal levels seen after a natural infection, doesn’t mean you end up with superior protection, at least not in the long run. Rather, it just means that your immune system gets “stuck” on a particular type of response, that will eventually start causing problems once the virus starts to mutate. Reckless interventions in complex systems tends to result in destructive outcomes.

With an immune system stuck on Wuhan, any novel variant of SARS2 that evolves far away from the original Wuhan spike can infect people, without the antibodies against the RBD shifting to versions that can keep that novel version from returning. That’s what happened with Omicron: It evolved far away from Wuhan, infects people, the Wuhan antibodies then mutate a little to deal with the new Omicron version, but are less effective than a novel antibody response would have been. Or, in fancy scientific language: “Repertoire analysis shows that the original Wuhan antigenic sin drives the convergent expansion of the same B cell germlines in vaccinated and SH cohorts. “

People will say that the hCovs also regularly reinfect us every year. That is correct, but it doesn’t follow from this, that SARS2 has to regularly reinfect us. After all, the risk of reinfection depends on the strength of the immune response developed against a pathogen. The strength of the immune response developed against a pathogen, depends on its virulence.

The reason the hCov viruses get to reinfect you, despite mutating less rapidly than Influenza, is because the hCov viruses are generally mild. Influenza in contrast, only infects around 8% of adults per year. Only 5% of people who catch influenza, catch it again within five years. Now consider that Influenza mutates 23 times faster than SARS-COV-2 and you start to see the issue. It’s very strange, to see that most people are still being infected by this SARS-COV-2 virus once or twice a year, especially now in 2024, when everyone is supposed to have some immunity against it.

There is only one proper explanation for this: We broke something. When you realize we broke something, all the puzzle pieces start to fall into place. You realize why we see people constantly get reinfected. You realize why we have these massive waves of this virus in summer, unlike any other respiratory virus. You realize why the original Omicron could spread so rapidly.

In essence, the message that we broke something, is a message of hope. If you can accept that you broke something, you can also repair it. This nightmare we now live in, with a doubling in long COVID cases in children every year, with people losing two IQ points with every reinfection, with all this mass sickness in the middle of summer, does not have to be the “new normal” from now on. In addition, it means we won’t have to isolate ourselves from the respiratory viruses that have been with us for generations, that constantly train our immune systems to help protect us from the nastier ones lurking in other animals.

So what is preventing herd immunity? The answer mostly comes down to the existence of a demographic of people, who have been repeatedly vaccinated and whose innate immune system has failed to adjust to the demands placed upon it by the new SARS2 virus. This failure of the innate immune system to control the virus, is masked by these persistently high concentrations of antibodies. The concentrations of those antibodies rises whenever these people are reinfected, until they rise high enough to suppress the infection. Then the concentrations decline again, but the virus will have already had the opportunity to use this host to release viral aerosols into the air, through which it can jump into other people.

So who are these people? Well fortunately, we have scientific evidence that gives us an answer:

In our observational cohort study of the exhaled breath particles of 194 healthy human subjects, and in our experimental infection study of eight nonhuman primates infected, by aerosol, with SARS-CoV-2, we found that exhaled aerosol particles vary between subjects by three orders of magnitude, with exhaled respiratory droplet number increasing with degree of COVID-19 infection and elevated BMI-years. We observed that 18% of human subjects (35) accounted for 80% of the exhaled bioaerosol of the group (194), reflecting a superspreader distribution of bioaerosol analogous to a classical 20:80 superspreader of infection distribution.

People with more severe infections, release more aerosols. This makes sense. But more importantly, more obese and elderly people also release more aerosols, even if they don’t get severely ill. We have this graph, to illustrate this:

1spreadagebmi-1024x467.jpg


The authors explicitly mention:

We note that all volunteers of <26 y of age and all subjects under 22 BMI were low spreaders of exhaled bioaerosol.

You might argue that these very low doses of aerosols can still transmit the virus. But that brings us to the issue of infectious dose. How sick you get from a virus, depends on the initial dose you are exposed to. A greater dose means a virus gets the opportunity to overwhelm your innate immune response. It also means increased genetic diversity of the population, which also increases virulence.

And because you become more ill when exposed to a greater infectious dose, you then also end up producing more viral particles yourself, which means you are more likely to end up passing it on yourself.

If you follow this logic to its natural conclusion, you’ll understand that the continuation of the pandemic, which is continuing to result in brain damage in children, is a consequence of the fact that through vaccination we have created an entire demographic of elderly and obese individuals, whose innate immune systems fail to control this virus and who continue to pass on this virus, but don’t get severely ill because eventually their antibody concentration rises enough to suppress the infection.

It is in essence, what I warned about back in 2020: The young are being asked to make sacrifices for the old. The sacrifices did not end when the lockdowns ended. Rather, the sacrifices have merely grown over time. We now see long COVID in 20% of children and 13% of teenagers. Your body is not meant to be reinfected by a SARS virus every year. And because long COVID is accompanied by damage to the immune system, we’re making the long term outcome of all of this much, much, much worse.

Herd immunity, requires those individuals of the herd who can’t develop immunity, to be removed from the herd. We used vaccines, to mask which individuals of the herd are unable to develop immunity against this virus. That sounds ruthless, but nature has a habit of being ruthless. Like science, it does not really care about our feelings.

We’re now rapidly reaching the point, where the technological masking of the problem comes to an end. The virus inevitably figures out eventually how to make people’s antibody response against it useless. This will result in huge numbers of deaths, it will end up killing far more people than would have died without any attempt at vaccination.

We can’t isolate children and teenagers from this virus, unless you would propose they:

-Never go to the dentist

-Never go swimming

-Never play sports

-Never kiss each other

All of this was obvious back in march 2020. The nature of the story hasn’t really changed since then:

The purpose of life, is to find something you’re willing to die for. But some people are so afraid of death, they would readily ask sacrifices from the next generation, to extend their own lives a little longer.

The only thing that changed, is the immensity of the sacrifices now demanded of the young.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


Cows That Are Dropping Dead From H5N1 Avian Flu Are “Piled Up Along The Roadside” In California
Michael Synder
October 21, 2024

Are we are on the verge of the worst public health crisis that any of us have ever witnessed? I just read a report from the Los Angeles Times that chilled me to the core. I knew that H5N1 avian flu was infecting dairy cows all over the nation, but I had no idea that things had gotten so bad. California produces more dairy than any other state, and so prices for milk, cheese and other dairy products will inevitably go up as herd after herd gets devastated by this insidious disease. More importantly, if H5N1 avian flu starts spreading among humans on a widespread basis, the panic that we will see will be off the charts.

This wasn’t supposed to happen.

We were told that even though millions of birds were dying, H5N1 avian flu would not start spreading widely among mammals.

But now it is.

At this moment, dead cows are “stacked along roadsides rotting in the heat” in some areas of California…

A dystopian scene is emerging in California as dairy farmers battle a ruthless disease.
Dead cows and calves stacked along roadsides rotting in the heat surrounded by crows, vultures and thick swarms of black flies.
After wiping out tens of millions of birds worldwide, the H5N1 avian flu is tearing through dairy farms in the US.

I know that everyone wants to talk about the presidential election right now, but this is important.

Cows are dropping dead in large numbers, and there is no end to this crisis in sight.

According to the Los Angeles Times, things are particularly bad in Tulare County…

There’s a sickness hovering over Tulare County‘s dairy industry.
On a recent 98-degree afternoon, dead cows and calves were piled up along the roadside. Thick swarms of black flies hummed and knocked against the windows of an idling car, while crows and vultures waited nearby — eyeballing the taut and bloated carcasses roasting in the October heat.

So far, 124 dairy herds have been hit in the state of California alone.

The San Joaquin Valley seems to be the current epicenter of this crisis. According to one industry insider, his drivers “picked up 20 to 30 animals at one farm in one day”…

A similar observation was made by Jimmy Andreoli II, spokesman for Baker Commodities, a rendering company with facilities in Southern California. He said his workers are picking up a surge of dead cows throughout the San Joaquin Valley.
“There’s definitely been an increased number of fallen animals lately, and some of that has got to be attributed to the long, hot summer we’ve had. And some of it, you know, certainly is attributed to the H5N1 virus,” he said, noting that one of his drivers picked up 20 to 30 animals at one farm in one day.
Andreoli said that at some farms the cows are intentionally being left on the roadside to reduce contamination — preventing further inter-farm spread. At others, the animals are left on-site — but away from live animals and people.

When dead cows are picked up, they are transported to a rendering site for processing…

Infected carcasses are being brought to a rendering site – a facility that processes animal remains – to be turned into ‘high protein’ animal feed and fertilizer, or liquids used into used in fuels, paints, varnishes, lubricants and other industrial products.
Removing and processing these carcasses eliminates the risk of them passing bird flu onto other animals or humans.
California is the nation’s largest dairy producer, and this state currently holds the record for the most bird flu-infected cattle herds in a single state, in addition to a high number of cases among dairy workers.

If this disease continues to spread like wildfire in California, it is going to have enormous implications for all of us.

Because if dairy prices go through the roof there, they are going to go through the roof everywhere.

And it doesn’t appear that much is being done to prevent this disease from spreading.

For example, one California veterinarian says that she has seen sick and healthy cows right next to one another…

In a video posted on X, California-based veterinarian Crystal Health shows a cattle pen that appears to contain both sick and healthy cows, with a ‘questionable’ number of them lying down.
‘The sick cows are supposed to be separated from the healthy ones,’ she wrote.
Not sure what’s happening here but a lot of the cows were laying down, and some flat out. The rendering truck did come to this facility in the morning, but no dead pile was visible from the road.’

I don’t know why the dairy industry is not taking this outbreak more seriously.

What is going to happen if half of the dairy cows in the state of California get infected?

And what is going to happen if H5N1 avian flu starts passing from human to human on a widespread basis?

According to one local resident in Tipton, California a “lot of people” have gotten infected in her area…

“A lot of people have it,” said a woman working behind the cash register at Tipton’s Dollar General, one of the few stores in this small, agricultural community right off Highway 99.
The woman declined to provide her name, explaining her husband is a dairy worker in the country illegally in Tulare County; she said his job is not protected or secure, and she was fearful of retribution.
“So far the symptoms seem pretty mild,” she said. “People can keep working.”

Of course it isn’t just dairy workers in California that are getting infected.

In fact, we just learned that four dairy workers in Washington state “have preliminarily tested positive for bird flu”…

Four agricultural workers in southeast Washington have preliminarily tested positive for bird flu after working around an infected poultry flock at a commercial egg farm.
The cases, if confirmed, would be the first time people in Washington have contracted the virus since officials began tracking a notable rise of it in birds and other animals starting in the U.S. around 2022. Since then, upward of two dozen human cases have been detected across five other states — all but one tied to contact with infected animals.
Health officials emphasized that the four positive cases in Washington are “presumptive,” pending confirmation and analysis by the U.S. Centers for Disease Control and Prevention.

So far, there is no evidence that H5N1 avian flu is passing from person to person on a widespread basis.

But if that changes, we could be facing a nightmare.

According to the CDC, more than half of the humans that have been infected with H5N1 avian flu since January 1st, 2003 have ended up dead.

I don’t know if H5N1 avian flu will become the next great global pandemic, but without a doubt we live at a time when great pestilences will kill vast numbers of people.

So let’s watch this story very closely.

If the same thing that is happening to dairy cows in California starts happening to people, the level of panic that will erupt will be absolutely frightening to behold.
 

jward

passin' thru
Camus
@newstart_2024

Shocking...
Naomi Wolf: "Pfizer knew within three months that 1,225 people died. That's how many deaths there are in just three months of rollout. Pfizer knew by April of 2021 that minors' hearts were being damaged by the injection. They had warnings from the Israeli Health Ministry and also from a pediatric group.

And rather than coming forward and telling all of us this is going to damage the hearts of minors, our lawyers FOIA'd email chains that go up to Dr. Fauci, Dr. Walensky, POTUS, and 15 White House staffers. In the email, you see it going all the way. So the president can't say— The template goes to POTUS. Right. OK. A little deniability there, but the template goes to POTUS.

But certainly there are 15 White House staffers on the email chain, right? Being told, hello, we have a problem here. Worse. They were told that, but then there was this freak out, and I recognize it from having been an advisor to a presidential campaign, a freak out conference where they're planning how to lie to the American people, and they're creating a script.

The script is 17 pages, completely redacted. But you remember what happened in April and May of 2021. They came forward and said, oh, you know, pericarditis, myocarditis in young men and teenagers, it's transient, it's mild, it's rare that they knew that they were lying.

That's what they came out with. That was their approach. Correct. Like, we'll kind of admit it, but we'll just say it's really nothing to worry about. And then they followed that with an all summer long propaganda campaign using influencers and TikTok personalities to get young people and teenagers to get injected."


rt < 2m
View: https://twitter.com/newstart_2024/status/1848403326502891834
 
Top